Document:

EX-4.4

 Exhibit 4.4 

Execution Version 
  

 
  

DXC TECHNOLOGY COMPANY 

(F.K.A. EVERETT SPINCO, INC.), 
 as
Issuer 
 and 
 U.S. BANK
NATIONAL ASSOCIATION, 
 as Trustee 

NINTH SUPPLEMENTAL INDENTURE 

Dated as of September 9, 2021 

to 
 INDENTURE 

Dated as of March 27, 2017 
  

 
  

 This Ninth Supplemental Indenture, dated as of September 9, 2021 (this
“Supplemental Indenture”), between DXC TECHNOLOGY COMPANY, a Nevada corporation (f.k.a. Everett SpinCo, Inc.) (the “Company”), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the
“Trustee”). 
 Reconciliation and tie between Trust Indenture Act and the Indenture. 

 

			
	 § 310(a)
	  	5.10
	 (b)
	  	5.09
	 § 311(a)
	  	5.14
	 (b)
	  	5.14
	 § 312(a)
	  	2.08
	 (b)
	  	10.04
	 (c)
	  	10.04
	 § 313(a)
	  	5.04
	 (b)
	  	5.04
	 (c)
	  	5.04
	 (d)
	  	5.04
	 § 314(a)
	  	3.02
	 (b)
	  	Not Applicable
	 (c)
	  	10.05
	 (d)
	  	Not Applicable
	 (e)
	  	10.05
	 (f)
	  	Not Applicable
	 § 315(a)
	  	5.01
	 (b)
	  	4.12
	 (c)
	  	5.01
	 (d)
	  	5.05
	 (e)
	  	10.04
	 § 316(a)
	  	7.02, 7.07
	 (b)
	  	7.02
	 (c)
	  	6.02
	 § 317(a)
	  	4.03
	 (b)
	  	5.03
	 § 318(a)
	  	7.07

 Note: This reconciliation and tie shall not, for any purpose, be deemed to be part of the Indenture. 

RECITALS 
 WHEREAS, the
Company and the Trustee executed and delivered an indenture, dated as of March 27, 2017 (the “Base Indenture” and, together with this Supplemental Indenture, including the provisions of the Trust Indenture Act that are
automatically deemed to be a part of this Indenture by operation of the Trust Indenture Act, and as it may be further amended or supplemented from time to time with respect to the Notes, the “Indenture”), to provide for the issuance
by the Company from time to time of debentures, notes or other debt instruments evidencing its indebtedness. 
 WHEREAS, the Company has
authorized the issuance of (i) 1.800% Senior Notes due 2026 (the “2026 Notes”) and (ii) 2.375% Senior Notes due 2028 (the “2028 Notes” and, together with the 2026 Notes, the “Notes”). 

  
 2 

 WHEREAS, the Company desires to enter into this Supplemental Indenture to establish the
forms and terms of the Notes in accordance with Section 2.03 of the Base Indenture and to add covenants to and remove covenants from the Base Indenture with respect to the Notes. 

WHEREAS, all things necessary to make this Supplemental Indenture a valid and legally binding agreement according to its terms have been done.

 WHEREAS, the Indenture is subject to, and will be governed by, the provisions of the Trust Indenture Act that are required to be a part
of and govern indentures qualified under the Trust Indenture Act. 
 NOW, THEREFORE, for and in consideration of the foregoing premises, the
Company and the Trustee mutually covenant and agree for the equal and proportionate benefit of the respective Holders from time to time of the Notes as follows: 

ARTICLE 1 
 TERMS
OF THE NOTES 
 Section 1.01.    Terms of the Notes. The
following terms relate to the Notes: 
 (a)    The Notes shall constitute two separate series of Securities issued under
the Base Indenture to be designated (i) “1.800% Senior Notes due 2026” and (ii) “2.375% Senior Notes due 2028,” respectively. 

(b)    There are to be authenticated and delivered (i) $700,000,000 aggregate principal amount of the 2026 Notes and (ii)
$650,000,000 aggregate principal amount of the 2028 Notes. 
 (c)    The Company may from time to time, without the
consent of the Holders of the applicable series of Notes, issue Additional Notes having the same ranking and the same interest rate, maturity and other terms (except for the issue date and, in some cases, the public offering price and the first
Interest Payment Date) as the Initial Notes of such series. The aggregate principal amount of the Additional Notes of each series shall be unlimited. 

(d)    Any Additional Notes and the Initial Notes of such series shall constitute a single series under the Indenture and
all references to the Notes shall include the Initial Notes and any Additional Notes, unless the context otherwise requires; provided that if any such Additional Notes are not fungible with the previously issued Notes of such series for U.S.
federal income tax purposes, such Additional Notes will be issued with a different CUSIP number as the previously issued Notes of such series. 

(e)    The entire outstanding principal of (i) the 2026 Notes shall be payable on September 15, 2026 and
(ii) the 2028 Notes shall be payable on September 15, 2028. The rate at which the Notes shall bear interest shall be, (i) in the case of the 2026 Notes, 1.800% per year and, (ii) in the case of the 2028 Notes, 2.375% per year.
The date from which interest shall accrue on the Notes shall be September 9, 2021, or the most recent Interest Payment Date to which interest has been paid or provided for. The Interest Payment Dates for the Notes shall be March 15 and
September 15 of each year, beginning March 15, 2022. 
 (f)    Interest shall be payable on each Interest
Payment Date to the Holders of record of the Notes at the close of business on the day that is 15 calendar days prior to such Interest Payment Date (each, a “regular record date”). Interest shall be calculated on the basis of a 360-day year consisting of twelve 30-day months. 

  
 3 

 (g)    The Notes that are issued in a registered offering pursuant to
the Securities Act of 1933, as amended, shall, (i) in the case of the 2026 Notes, be substantially in the form attached hereto as Exhibit A and, (ii) in the case of the 2028 Notes, be substantially in the form attached hereto as
Exhibit B, in each case, the terms of which are herein incorporated by reference. Such Global Notes shall be deposited with the Depositary or its nominee, for credit to an account of an Agent Member, and shall be duly executed by the Company
and authenticated by the Trustee as hereinafter provided. The aggregate principal amount of a Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee, as hereinafter provided. 

(h)    The Depositary for the Global Notes shall be The Depository Trust Company, or its successors (the
“Depositary”). 
 (i)    Each Global Note (and all Notes issued in exchange therefor or substitution
thereof) shall bear the applicable legends set forth in Exhibit A (in the case of the 2026 Notes) or Exhibit B (in the case of the 2028 Notes) (collectively, the “Note Legends”) on the face thereof until the Note
Legends are removed or not required. 
 (j)    The Notes shall be denominated in Dollars and shall be issuable in
minimum denominations of $2,000 or any integral multiple of $1,000 in excess thereof. 
 (k)    The Notes may be
redeemed by the Company prior to the applicable maturity date, as provided in Section 1.05. 
 (l)    The Notes
will not have the benefit of any sinking fund. 
 (m)    Except as provided herein, the Holders of the Notes shall have
no special rights in addition to those provided in the Base Indenture upon the occurrence of any particular events. 

(n)    The Notes will be direct, unconditional, senior unsecured and unsubordinated obligations of the Company, and will
rank equal in right of payment to all of the Company’s other existing and future senior unsecured indebtedness and among themselves, and senior in right of payment to any subordinated indebtedness the Company may incur. 

(o)    The Notes are not convertible into shares of common stock or other securities of the Company. 

(p)    The restrictive covenants set forth in Section 1.07 shall be applicable to the Notes. 

Section 1.02.    Additional Defined Terms. As used herein, the following defined terms shall have the
following meanings with respect to the Notes only: 
 “2026 Notes” has the meaning set forth in the recitals hereto. 

“2028 Notes” has the meaning set forth in the recitals hereto. 

“Additional Notes” means any additional Notes of a particular series issued under the Indenture as part of such series of
Notes. 

  
 4 

 “Agent Members” has the meaning set forth in Section 1.09(b). 

“Applicable Procedures” means, with respect to any transfer or exchange of or for beneficial interests in any Global Note,
the rules and procedures of the Depositary, Euroclear and Clearstream that apply to such transfer or exchange at the relevant time. 

“Attributable Debt” means, with respect to any sale and lease-back transaction, the present value of the minimum rental
payments called for during the term of the lease (including any period for which such lease has been extended), determined in accordance with GAAP, discounted at a rate that, at the inception of the lease, the lessee would have incurred to borrow
over a similar term the funds necessary to purchase the leased assets. 
 “Base Indenture” has the meaning set forth in the
recitals hereto. 
 “Business Day” means any day other than a Saturday, a Sunday or a day on which banking institutions in
the City of New York are authorized or obligated by law, regulation or executive order to remain closed. 
 “Capital Lease
Obligations” means, at the time any determination is to be made, the amount of the liability in respect of a capital lease that would at that time be required to be capitalized on a balance sheet prepared in accordance with GAAP. 

“Change of Control” means the occurrence of any of the following: 

(1)    the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or
consolidation), in a single transaction or a series of related transactions, of all or substantially all of the Company’s assets and the assets of its Subsidiaries, taken as a whole, to one or more “persons” (as that term is defined
in Section 13(d)(3) of the Exchange Act) (other than to the Company or one of its Subsidiaries); 
 (2)    the
consummation of any transaction (including, without limitation, any merger or consolidation) as a result of which any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) becomes the beneficial owner (as defined in
Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50.0% of the Voting Stock of the Company, measured by voting power rather than number
of shares; 
 (3)    the Company consolidates with, or merges with or into any Person, or any Person consolidates with,
or merges with or into the Company, in any such event pursuant to a transaction in which any of the outstanding Voting Stock of the Company or such other person is converted into or exchanged for cash, securities or other property, other than any
such transaction where the shares of Voting Stock of the Company outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving Person immediately after giving
effect to such transaction; or 
 (4)    the adoption of a plan relating to the liquidation or dissolution of the
Company. 
 Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control if (i) (A) the Company becomes a direct or
indirect wholly owned subsidiary of a holding company and (B) the direct or indirect holders of the Company’s Voting Stock immediately prior to that transaction are the holders of more than 50.0% of the Voting Stock of such holding
company, or (ii) the Company consolidates with, or merges with or into, any person that results in the surviving person remaining a public company. 

  
 5 

 “Change of Control Offer” has the meaning set forth in
Section 1.07(d). 
 “Change of Control Payment” has the meaning set forth in Section 1.07(d). 

“Change of Control Payment Date” has the meaning set forth in Section 1.07(d). 

“Change of Control Triggering Event” means the occurrence of both a Change of Control and a Rating Event. 

“Clearstream” means Clearstream Banking, société anonyme, or its successors. 

“Company” means the Person named as the “Company” in the preamble hereto until a successor Person shall have
become such pursuant to the applicable provisions of this Indenture, and thereafter “Company” shall mean such successor Person. 

“Comparable Treasury Issue” means the United States Treasury security selected by the Independent Investment Banker as having
a maturity most comparable to the remaining term of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities with comparable
maturity to the remaining term of such Notes (assuming for this purpose that the Notes mature on the applicable Par Call Date). 

“Comparable Treasury Price” means, with respect to any Redemption Date, (i) the average of four Reference Treasury
Dealer Quotations for such Redemption Date, after excluding the highest and lowest such Reference Treasury Dealer Quotations, (ii) if the Independent Investment Banker obtains fewer than four such Reference Treasury Dealer Quotations, the
average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation. 

“Consolidated Net Tangible Assets” means, as of any particular time, the aggregate amount of the Company’s assets and
the assets of the Company’s Subsidiaries (in each case, less applicable reserves and other properly deductible items) after deducting from such amount: 

(1)    all current liabilities other than (A) notes and loans payable, (B) current maturities of long-term debt
and (C) current maturities of Capital Lease Obligations, and 
 (2)    intangible assets, to the extent included in
such aggregate assets, all as set forth on the Company’s then most recent consolidated balance sheet and computed in accordance with GAAP. 

“Definitive Security” means a certificated Note registered in the name of the Holder thereof and issued in accordance with
Section 2.01 of the Base Indenture. 
 “Depositary” has the meaning set forth in Section 1.01(h). 

“Euroclear” means Euroclear Bank SA/NV, or its successors. 

“Event of Default” has the meaning set forth in Section 1.08. 

  
 6 

 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Fitch” means Fitch Ratings, Inc., and its successors. 

“GAAP” means generally accepted accounting principles set forth in the opinions and pronouncements of the Public Company
Accounting Oversight Board (United States) and statements and pronouncements of the Financial Accounting Standards Board or in such other statements by such other entity as have been approved by a significant segment of the accounting profession,
which are in effect as of the date of this Indenture. 
 “Global Note” means, individually and collectively, each of the
Notes in global form issued to the Depositary or its nominee. 
 “Indebtedness” means, with respect to any Person, and
without duplication, any indebtedness, whether or not contingent, in respect of borrowed money or evidenced by bonds, notes, debentures or similar instruments or obligations under capital leases, except any such balance that constitutes an accrued
expense or trade payable, if and to the extent any of the foregoing indebtedness would appear as a liability upon an unconsolidated balance sheet of such Person in accordance with GAAP (but does not include contingent liabilities which appear only
in a footnote to a balance sheet); provided that Indebtedness shall exclude (A) Indebtedness that is required to be converted at, or prior to, maturity into equity securities of the Company, and (B) advances and overdrafts in
respect of cash pooling and multi-currency notional pooling programs. 
 “Independent Investment Banker” means an
independent investment institution of national standing, which may be one of the Reference Treasury Dealers or their respective affiliates, selected by the Company. 

“Initial Notes” means (i) with respect to the 2026 Notes, the first $700,000,000 aggregate principal amount of the 2026
Notes and (ii) with respect to the 2028 Notes, the first $650,000,000 aggregate principal amount of the 2028 Notes, in each case, issued under the Indenture on the date hereof. 

“Interest Payment Date” means the stated due date of an installment of interest on the Notes of each series. 

“Investment Grade Rating” means a rating equal to or higher than Baa3 (or the equivalent) by Moody’s; BBB- (or the equivalent) by S&P; and BBB- (or the equivalent) by Fitch, and the equivalent investment grade credit rating from any additional rating agency or Rating
Agencies selected by the Company. 
 “Lien” means any lien, security interest, charge or encumbrance of any kind (including
any conditional sale or other title retention agreement, any lease in the nature thereof, and any agreement to give any security interest). 

“Moody’s” means Moody’s Investors Service, Inc. and its successors. 

“Make-Whole Redemption Price” has the meaning set forth in Section 1.05(a). 

“Note Legends” has the meaning set forth in Section 1.01(i). 

  
 7 

 “Notes” has the meaning set forth in the recitals hereto. For purposes of
the Indenture, all references to the notes to be issued or authenticated upon transfer or replacement of or in exchange for Notes shall be deemed to refer to Notes. In addition, unless the context otherwise requires, all references to the
“Notes” shall include the Initial Notes and any Additional Notes. 
 “Par Call Date” means (i) with
respect to the 2026 Notes, August 15, 2026, and (ii) with respect to the 2028 Notes, July 15, 2028.  
 “Par
Call Redemption Price” has the meaning set forth in Section 1.05(a). 
 “Rating Agencies” means (1) each
of Moody’s, S&P and Fitch; and (2) if any of Moody’s, S&P or Fitch ceases to rate any series of Notes or fails to make a rating of any series of Notes publicly available for reasons outside of the control of the Company, a
“nationally recognized statistical rating organization” within the meaning of Section 3(a)(62) under the Exchange Act selected by the Company as a replacement agency for Moody’s, S&P or Fitch, as the case may be. 

“Rating Event” means, with respect to any series of Notes, the rating on such Notes is lowered by at least two of the three
Rating Agencies and such Notes are rated below an Investment Grade Rating by at least two of the three Rating Agencies on any day during the period (which period will be extended so long as the rating of such Notes is under publicly announced
consideration for a possible downgrade by any of the Rating Agencies) commencing on the earlier of the date of the first public occurrence of a Change of Control or the date of public notice of an agreement that, if consummated, would result in a
Change of Control and ending 60 days following consummation of such Change of Control. 
 “Redemption Date” means, when
used with respect to any Note to be redeemed, the date fixed for such redemption by or pursuant to this Indenture. 
 “Redemption
Price” has the meaning set forth in Section 1.05(a). 
 “Reference Treasury Dealer” means (i) BofA
Securities, Inc., Citigroup Global Markets Inc. and J.P. Morgan Securities LLC and their respective successors; provided, however, that if any of the foregoing ceases to be a primary U.S. government securities dealer in New York City
(a “Primary Treasury Dealer”), the Company will substitute another Primary Treasury Dealer; and (ii) any other Primary Treasury Dealer selected by the Company. 

“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer at any Redemption Date, the
average, as determined by the Independent Investment Banker, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the Independent Investment Banker by
such Reference Treasury Dealer at 3:30 p.m., New York City time, on the third Business Day preceding such Redemption Date. 

“regular record date” has the meaning set forth in Section 1.01(f). 

“Restricted Subsidiary” means any Subsidiary (a) substantially all the property of which is located, or substantially
all the business of which is carried on, within the United States, or (b) which holds more than 5.0% of the Company’s Consolidated Net Tangible Assets; except for any Subsidiary primarily engaged in financing receivables or in the finance
business. 
 “S&P” means S&P Global Ratings, a division of S&P Global, Inc., and its successors. 

  
 8 

 “Subsidiary” of any specified Person means any corporation, association or
other business entity of which more than 50.0% of the total voting power of shares of capital stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or trustees thereof is at the time
owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof. 

“Supplemental Indenture” has the meaning set forth in the preamble hereto. 

“Treasury Rate” means, with respect to any Redemption Date, the rate per annum equal to the semi-annual equivalent
yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such Redemption Date. 

“Trust Indenture Act” means the Trust Indenture Act of 1939, as amended, and the rules and regulations thereunder as in
effect on the date of this Indenture, except to the extent that the Trust Indenture Act or any amendment thereto expressly provides for application of the Trust Indenture Act as in effect on another date. 

“Trustee” has the meaning set forth in the preamble hereto. 

“United States” means the United States of America (including the states and the District of Columbia and any political
subdivision thereof). 
 “Voting Stock” of any specified Person as of any date means the capital stock of such Person that
is at the time entitled to vote generally in the election of the board of directors of such Person. 

Section 1.03.    Trust Indenture Act Provisions. Whenever this Indenture refers to a provision of the Trust
Indenture Act, that provision is incorporated by reference in and made a part of this Indenture. This Indenture shall also include those provisions of the Trust Indenture Act required to be included herein by the provisions of the Trust Indenture
Reform Act of 1990. The following Trust Indenture Act terms used in this Indenture have the following meanings: 
 “indenture
securities” means the Notes; 
 “indenture security holder” means a Holder of a Note; 

“indenture to be qualified” means the Indenture; 

“indenture Trustee” or “institutional Trustee” means the Trustee; and 

“obligor” on the indenture securities means the Company or any other obligor on the Notes. 

All other terms used in this Indenture that are defined in the Trust Indenture Act, defined by Trust Indenture Act reference to another
statute or defined by any Securities and Exchange Commission rule and not otherwise defined herein have the meanings assigned to them therein. 

Section 1.04.    Payment, Transfer and Exchange. 

(a)    Registration of Transfer and Exchange. To permit registrations of transfers and exchanges, the Company shall
execute a new Note or Notes of the same series as the Note presented 

  
 9 

 
for a like aggregate principal amount and in authorized denominations and the Trustee shall authenticate and deliver such Note or Notes upon receipt of an Issuer Order for the authentication and
delivery of such Notes. 
 All Notes issued upon any registration of transfer or exchange of Notes shall be the valid obligations of the
Company, evidencing the same indebtedness, and entitled to the same benefits under this Indenture, as the Notes surrendered upon such registration of transfer or exchange. Prior to such due presentment for the registration of a transfer of any Note,
the Trustee, the Company, any paying agent and the Registrar may deem and treat the person in whose name any Note is registered as the absolute owner of such Note for the purpose of receiving payment of principal of and interest on such Notes and
for all other purposes, and none of the Trustee, the Company, the paying agent or the Registrar shall be affected by notice to the contrary. 

All certifications, certificates and opinions of counsel which may be required to be submitted to the Trustee to effect a registration of
transfer or exchange may be submitted by e-mail or facsimile, to be followed by originals. 

(b)    Payment. The principal and interest on Notes represented by Global Securities will be payable to the
Depositary or its nominee, as the case may be, as the sole registered owner and the sole Holder of the Global Securities represented thereby. 

(c)    Transfer and Exchange of Beneficial Interests in the Global Securities. The transfer and exchange of
beneficial interests in the Global Securities shall be effected through the Depositary, in accordance with the provisions of this Indenture and the Applicable Procedures. Beneficial interests in any Global Note may be transferred to persons who take
delivery thereof in the form of a beneficial interest in a Global Note. 
 Section 1.05.    (a) Optional
Redemption. The provisions of Article 11 of the Base Indenture, as amended by the provisions of this Supplemental Indenture, shall apply to the Notes. Prior to the applicable Par Call Date, the Notes are redeemable, in whole or in part, at the
Company’s option, at any time and from time to time, at a redemption price (the “Make-Whole Redemption Price”) equal to the greater of: 

(i)    100.0% of the principal amount of such Notes to be redeemed; and 

(ii)    as determined by the Independent Investment Banker, the sum of the present values of the remaining
scheduled payments of principal and interest thereon (calculated as if the maturity date of the Notes is the applicable Par Call Date), exclusive of interest accrued and unpaid as of the Redemption Date, discounted to the Redemption Date on a
semi-annual basis at the Treasury Rate plus 15 basis points, in the case of the 2026 Notes, or 20 basis points, in the case of the 2028 Notes, 
 plus, in
each case, accrued and unpaid interest thereon to, but excluding, the Redemption Date. 
 On or after the applicable Par Call Date, the
Notes will be redeemable, in whole or in part at any time and from time to time, at a redemption price (the “Par Call Redemption Price” and, together with the Make-Whole Redemption Price, each a “Redemption Price”)
equal to 100.0% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest thereon to, but excluding, the Redemption Date. 

  
 10 

 (b)    Unless the Company defaults in payment of the Redemption Price,
on and after any Redemption Date for the Notes to be redeemed, interest shall cease to accrue on such Notes or portions thereof called for redemption. 

(c)    Notice of any redemption with respect to the Notes shall be given in the manner provided for in Section 11.02
of the Base Indenture on at least 10 days’ but not more than 90 days’ prior notice to the Redemption Date, to each Holder of Notes to be redeemed, except that redemption notices may be delivered more than 90 days prior to a Redemption Date
if such notice is issued in connection with a defeasance of the Notes or a satisfaction and discharge of the Indenture. 

(d)    At any time, the Company may repurchase Notes in the open market and may hold such Notes or surrender such Notes to
the Trustee for cancellation pursuant to Section 2.10 of the Base Indenture. 
 (e)    For the avoidance of doubt,
the Trustee shall not be required to calculate the Redemption Price or the Treasury Rate. 

Section 1.06.    Mandatory Redemption. The Company is not required to make mandatory redemption or sinking
fund payments with respect to the Notes. 
 Section 1.07.    Additional Covenants. The following additional
covenants shall apply with respect to the Notes so long as any of the Notes remain outstanding: 
 (a)    Limitation
on Liens. Other than as provided in Section 1.07(c) below, neither the Company nor any of its Restricted Subsidiaries may create, incur, assume or suffer to exist any Lien upon any of the Company’s property, to secure any Indebtedness
of the Issuer or a Restricted Subsidiary, except for: 
 (i)    Liens existing on the date hereof and any
extension, renewal or replacement (or successive extensions, renewals or replacements) of any such Lien; provided that no such extension, renewal or replacement will extend to or cover any property other than the property covered by such
existing Lien; 
 (ii)    Liens on property existing at the time the Company or any of its Restricted
Subsidiaries acquires such property; provided that such Liens: 
 (A)    are not incurred in
connection with, or in contemplation of the acquisition of the property acquired; and 
 (B)    do not
extend to or cover any of the Company’s property or any of its Restricted Subsidiaries’ property other than the property so acquired; 

(iii)    Liens on any property of a corporation or other entity existing at the time such corporation or
entity becomes the Company’s Restricted Subsidiary or is merged into or consolidated with the Company or a Restricted Subsidiary or at the time of a sale, lease 

  
 11 

 
or other disposition of the properties of such corporation or entity as an entirety or substantially as an entirety to the Company or a Restricted Subsidiary; provided that such Liens:

 (A)    are not incurred in connection with or in contemplation of such corporation or entity becoming
a Restricted Subsidiary or merging or consolidating with the Company or a Restricted Subsidiary or are not incurred in connection with or in contemplation of the sale, lease or other disposition of the properties of such corporation or other entity;
and 
 (B)    do not extend to or cover any of the Company’s property or any of its Restricted
Subsidiaries’ property other than the property of such corporation or other entity; 

(iv)    purchase money Liens upon or in any real or personal property (including fixtures and other
equipment) that the Company or any of its Restricted Subsidiaries hold or have acquired to secure the purchase price of such property or to secure Indebtedness incurred solely to finance or refinance the acquisition or improvement of such property
and incurred within 270 days after completion of such acquisition or improvement; 
 (v)    Liens to
secure Indebtedness owing to the Company or to a Restricted Subsidiary; 
 (vi)    Liens for taxes,
assessments or other governmental charges not yet due or payable or not overdue for a period of more than 60 days or that are being contested by the Company or a Restricted Subsidiary, and for which the Company maintains adequate reserves in
accordance with GAAP, and attachment, judgment and other similar Liens arising in connection with legal proceedings; provided that any such judgment does not constitute an Event of Default; 

(vii)    Liens in favor of the United States to secure amounts paid to the Company or any of its Restricted
Subsidiaries as advance or progress payments under government contracts entered into by it so long as such Liens cover only (x) special bank accounts into which only such advance or progress payments are deposited and (y) supplies covered
by such government contracts and material and other property acquired for or allocated to the performance of such government contracts; 

(viii)    Liens incurred in connection with an asset acquisition or a project financed with a non-recourse obligation; 
 (ix)    Liens in favor of suppliers,
producers, operators, workmen, materialmen, mechanics, workmen or repairmen, landlord’s Liens for rent or other similar Liens arising, in each case, in the ordinary course of business in respect of obligations which are not overdue or which are
being contested by the Company or any Restricted Subsidiary in good faith and by appropriate proceedings; 

(x)    Liens consisting of zoning restrictions, licenses, easements, covenants, rights-of-way, utility easements, building restrictions and similar encumbrances and restrictions on the use of real property and minor irregularities that do not materially
impair the use of the real property; 
 (xi)    Liens arising under leases or subleases of real or
personal property that do not, individually or in the aggregate, materially detract from the value of such real or personal property or materially interfere with the ordinary conduct of the business conducted at such real property or with respect to
such personal property; 

  
 12 

 (xii)    Liens arising under licenses or sublicenses of
intellectual property granted in the ordinary course of business; 
 (xiii)    Liens arising by reason of
deposits with, or giving any form of security to, any governmental agency or any body created or approved by law or government regulation; 

(xiv)    Liens created by or resulting from any litigation or other proceeding that is being contested in
good faith by appropriate proceedings, including Liens arising out of judgments or awards against the Company or any Restricted Subsidiary with respect to which the Company or any of its Restricted Subsidiaries is in good faith prosecuting an appeal
or proceedings for review for which the time to make an appeal has not yet expired, and Liens relating to final unappealable judgments that are satisfied within 60 days of the date of judgment or Liens incurred by the Company or any Restricted
Subsidiary for the purposes of obtaining a stay or discharge in the course of any litigation proceeding to which the Company or any of its Restricted Subsidiaries is a party; 

(xv)    Liens on deposits securing obligations under cash pooling and multi- currency notional pooling
programs; 
 (xvi)    Liens relating to hedging and similar arrangements entered into in the ordinary
course of business, including without limitation interest rate or foreign currency hedging arrangements; 

(xvii)    Liens incurred or deposits made by the Company or its Restricted Subsidiaries in the ordinary
course of business in connection with workers’ compensation, unemployment insurance and other types of social security benefits, taxes, assessments, statutory obligations or other similar charges, or to secure the performance of tenders,
statutory obligations, bids, leases, government contracts, performance and return-of-money bonds or other similar obligations (exclusive of obligations for the payment
of borrowed money); 
 (xviii)    Liens on account receivables or related assets resulting from the sale
of such account receivables or such related assets, or Liens arising in connection with or related to any securitization financings, factoring arrangements or assignments thereof that may be entered into by the Company or any Restricted Subsidiary;

 (xix)    Liens, pledges or deposits made in the ordinary course of banking arrangements in connection
with any netting or set-off arrangements for the purpose of netting debit and credit balances; 

(xx)    Liens on property incurred in sale and lease-back transactions permitted under
Section 1.07(b); and 
 (xxi)    Liens constituting any extension, renewal or replacement of any
Liens in provisions (i) to (xx) above to the extent the principal amount of the Indebtedness secured by such Lien is not increased (except to the extent of any premiums, fees or other costs associated with any such extension, renewal or
replacement) and the property encumbered by any such Lien is the same as or substantially similar in nature to the property encumbered by the Lien being extended, renewed or replaced. 

  
 13 

 Notwithstanding the foregoing, the Company or any of its Restricted Subsidiaries may create, incur, assume
or suffer to exist Indebtedness secured by Liens not otherwise permitted by this Section 1.07(a) if the Company first makes effective provisions whereby the Notes (together with any other Indebtedness of the Company then existing or thereafter
created ranking equally with such Notes and similarly entitled to be equally and ratably secured) shall be secured equally and ratably with such Indebtedness for so long as such Indebtedness shall so be secured. 

(b)    Limitation on Sale and Lease-back Transactions. Other than as provided in Section 1.07(c) below,
neither the Company nor any of its Restricted Subsidiaries may enter into any sale and lease-back transaction with a term longer than three years, unless: 

(i)    such transaction was entered into prior to the date hereof; 

(ii)    such transaction was for the sale and leasing back to the Company of any property by one of its
Restricted Subsidiaries; 
 (iii)    the Company would be entitled to incur Indebtedness secured by a
mortgage on the property to be leased in an amount equal to the Attributable Debt with respect to such sale and lease-back transaction without equally and ratably securing the notes pursuant to Section 1.07(a) above; or 

(iv)    the Company applies an amount equal to the fair value of the property sold to the purchase of
property or to the retirement of its long-term Indebtedness (including the Notes) within 365 days of the effective date of any such sale and lease-back transaction. 

(c)    Permitted Liens and Permitted Sale and Lease-back Transactions. Notwithstanding the restrictions set forth
under Section 1.07(a) and Section 1.07(b), the Company or any of its Restricted Subsidiaries may create, incur, assume or suffer to exist any Lien or enter into any sale and lease-back transaction not otherwise permitted pursuant to
Section 1.07(a) or Section 1.07(b); provided that, at the time of such event, and after giving effect to that event, the aggregate amount of all Indebtedness secured by Liens permitted by this Section 1.07(c) (excluding the
Liens permitted pursuant to Section 1.07(a)) and the aggregate amount of all Attributable Debt in respect of sale and lease-back transactions permitted by this Section 1.07(c) (excluding sale and lease-back transactions permitted under
Section 1.07(b)) measured, in each case, at the time any such Lien is incurred or any such sale and lease-back transaction is entered into, by the Company or any Restricted Subsidiary does not exceed 20.0% of the Company’s Consolidated Net
Tangible Assets. 
 (d)    Purchase of Notes upon a Change of Control Triggering Event. (i) If a Change of
Control Triggering Event occurs with respect to a series of Notes, unless the Company has exercised its option to redeem such Notes as described in Section 1.05 hereof, the Company will make an offer (a “Change of Control
Offer”) to each Holder of such Notes to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that Holder’s Notes at a repurchase price, payable in cash, equal to 101.0% of the aggregate
principal amount of Notes repurchased, plus accrued and unpaid interest, on the Notes repurchased to, but excluding, the date of repurchase (the “Change of Control Payment”). Within 30 days following any Change of Control Triggering
Event or, at the Company’s option, prior to any Change of Control, but after public announcement of the transaction that constitutes or may constitute the Change of Control, a notice will be sent to Holders of the Notes, with a copy to the
Trustee, describing the transaction that constitutes or may constitute the Change of Control Triggering Event and offering to repurchase such Notes on the date specified in the notice, which date will be no earlier than 10 days and no later than 90
days from the date such notice is delivered (the “Change of Control Payment  

  
 14 

 
Date”). The notice will, if delivered prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Triggering
Event occurring on or prior to the Change of Control Payment Date and shall state the following: 

(A)    that the Change of Control Offer is being made pursuant to this Section 1.07(d) and that all
Notes tendered will be accepted for payment; 
 (B)    the purchase price and the purchase date, which
shall be no earlier than 10 days and no later than 90 days from the date such notice is mailed; 

(C)    that any Note not tendered will continue to accrue interest; 

(D)    that, unless the Company defaults in the payment of the Change of Control Payment, all Notes
accepted for payment pursuant to the Change of Control Offer will cease to accrue interest after the Change of Control Payment Date; 

(E)    that Holders electing to have any Notes purchased pursuant to a Change of Control Offer will be
required to surrender the Notes, with the form entitled “Option of Holder to Elect Purchase” attached to the Notes completed, or transfer by book-entry transfer, to the paying agent at the address specified in the notice prior to the close
of business on the third Business Day preceding the Change of Control Payment Date; 
 (F)    that
Holders will be entitled to withdraw their election if the paying agent receives, not later than the close of business on the second Business Day preceding the Change of Control Payment Date, a telegram, telex, facsimile transmission or letter
setting forth the name of the Holder, the principal amount of Notes delivered for purchase, and a statement that such Holder is withdrawing his election to have the Notes purchased; and 

(G)    that Holders whose Notes are being purchased only in part will be issued new Notes equal in
principal amount to the unpurchased portion of the Notes surrendered, which unpurchased portion must be equal to $2,000 in principal amount or an integral multiple of $1,000 in excess thereof. 

The Company will comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and
regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any securities laws or
regulations conflict with the provisions of this Section 1.07(d), the Company will comply with the applicable securities laws and regulations and will not be deemed to have breached its obligations under this Section 1.07(d) by virtue of
such compliance. 
 (ii)    On the Change of Control Payment Date, the Company will, to the extent
lawful: 
 (A)    accept for payment all Notes or portions of Notes properly tendered pursuant to the
Change of Control Offer; 

  
 15 

 (B)    deposit with the paying agent an amount equal to
the Change of Control Payment in respect of all Notes or portions of Notes properly tendered; and 

(C)    deliver or cause to be delivered to the Trustee the Notes properly accepted together with an
Officers’ Certificate stating the aggregate principal amount of Notes or portions of Notes being repurchased. 
 The paying agent will promptly deliver
(but in any case not later than five days after the Change of Control Payment Date) to each Holder of Notes properly tendered the Change of Control Payment for such Notes, and the Trustee will promptly authenticate and deliver (or cause to be
transferred by book entry) to each Holder a new Note equal in principal amount to any unpurchased portion of the Notes surrendered, if any. The Company will publicly announce the results of the Change of Control Offer on or as soon as practicable
after the Change of Control Payment Date. 
 (iii)    Notwithstanding anything to the contrary in this
Section 1.07(d), the Company will not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if (a) a third party makes such an offer in the manner, at the times and otherwise in
compliance with the requirements set forth in this Section 1.07(d) and the third party repurchases all Notes properly tendered and not withdrawn under its offer, or (b) notice of redemption has been given pursuant to Section 1.05
hereof, unless and until there is a default in payment of the applicable Redemption Price. 

Section 1.08.    Defaults and Remedies. (a) Events of Default. This Section 1.08(a) shall
replace Section 4.01 of the Base Indenture with respect to the Notes only. 
 Each of the following is an “Event of
Default” with respect to a series of Notes: 
 (i)    default in the payment of interest on such
Notes when due, and such default has continued for a period of 90 days or more and the time for such payment is due has not been extended or deferred; 

(ii)    default in the payment (at maturity, upon redemption or otherwise) of the principal of such Notes
when due; 
 (iii)    failure by the Company for 90 days after notice to the Company by the Trustee or
the Holders of at least 25.0% in aggregate principal amount of such Notes then Outstanding to perform or observe any of the other covenants or agreements in this Indenture applicable to such series (other than defaults specified in clauses
(i) or (ii) above); 
 (iv)    any of the Company’s Indebtedness in the aggregate outstanding
principal amount of $250 million or more either: 
 (A)    becomes due and payable prior to the due
date for payment of such Indebtedness by reason of acceleration of such Indebtedness following a default by the Company; or 

(B)    is not repaid at, and remains unpaid after, maturity as extended by any applicable period of grace
or any guarantee given by the Company in respect of Indebtedness of any other Person in the aggregate outstanding principal amount of $250 million or more is not honored when, and remains dishonored after, becoming due; 

  
 16 

 (v)    the Company pursuant to or within the meaning of
any Bankruptcy Law (A) commences a voluntary case, (B) consents to the entry of an order for relief against it in an involuntary case, (C) consents to the appointment of a custodian of it or for all or substantially all of its
property or (D) makes a general assignment for the benefit of its creditors; or 
 (vi)    a court
of competent jurisdiction enters an order or decree under any Bankruptcy Law that (A) is for relief against the Company in an involuntary case, (B) appoints a custodian of the Company for all or substantially all of the Company’s
properties, or (C) orders the liquidation of the Company, and, in any of the above cases, the order or decree remains unstayed and in effect for 90 days. 

(b)    Acceleration of Maturity. In the case of an Event of Default specified in clause (v) or (vi) of
Section 1.08(a), all outstanding Notes of the applicable series will become due and payable immediately without further action or notice. If any other Event of Default occurs and is continuing, the Trustee or the Holders of at least 25.0% in
aggregate principal amount of the then Outstanding Notes of such series may declare all such Notes to be due and payable immediately by notice in writing to the Company (and to the Trustee if written notice is given by such Holders). Upon any such
declaration, the Notes shall become due and payable immediately. 
 The Holders of a majority in aggregate principal amount of the then
Outstanding Notes of a particular series by written notice to the Trustee may, on behalf of all of the Holders of such series, rescind an acceleration and its consequences with respect to such Notes, if the rescission would not conflict with any
judgment or decree and if all existing Events of Default with respect to such Notes (except nonpayment of principal, interest or premium that has become due solely because of the acceleration) have been cured or waived. 

Section 1.09.    Book-Entry Provisions for Global Notes. (a) Each Global Note initially shall (i) be
registered in the name of the Depositary for such Global Note or the nominee of such Depositary, in each case for credit to the account of an Agent Member, and (ii) be delivered to the Depositary. None of the Company, any agent of the Company
or the Trustee shall have any responsibility or liability for any aspect of the records relating to or payments made on account of beneficial ownership interests of a Global Note, or for maintaining, supervising or reviewing any records relating to
such beneficial ownership interests. 
 (b)    Members of, or participants and account holders in, the Depositary
(“Agent Members”) shall have no rights under this Indenture with respect to any Global Note held on their behalf by the Depositary, or its custodian, or under such Global Notes. The Depositary or its nominee, as the case may be, may
be treated by the Company, any other obligor upon the Notes, the Trustee and any agent of any of them as the absolute owner of the Global Notes for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, any
other obligor upon the Notes, the Trustee or any agent of any of them from giving effect to any written certification, proxy or other authorization furnished by the Depositary or impair, as between the Depositary and its Agent Members, the operation
of customary practices governing the exercise of the rights of a beneficial owner of any Note. The Holder of a Global Note may grant proxies and otherwise authorize any Person, including Agent Members and Persons that may hold interests through
Agent Members, to take any action that a Holder is entitled to take under this Indenture or the Notes. 

  
 17 

 (c)    Transfers of a Global Note shall be limited to transfers of such
Global Note in whole, but, subject to the immediately succeeding sentence, not in part, to the Depositary, its successors or their respective nominees. Interests of beneficial owners in a Global Note may not be transferred or exchanged for physical
Notes unless (i) the Company has consented thereto in writing, or such transfer or exchange is made pursuant to the next sentence, and (ii) such transfer or exchange is in accordance with the Applicable Procedures. Subject to the
limitation on issuance of physical Notes, physical Notes shall be transferred to all beneficial owners in exchange for their beneficial interests in the relevant Global Note, if (i) the Depositary notifies the Company at any time that it is
unwilling or unable to continue as Depositary for the Global Notes and a successor depositary is not appointed within 90 days; or (ii) the Company, at its option, notifies the Trustee that it elects to cause the issuance of physical Notes. 

(d)    The transfer and exchange of a Global Note or beneficial interests therein shall be effected through the
Depositary, in accordance with the Indenture (including applicable restrictions on transfer set forth in Section 1.10) and the Applicable Procedures therefor of the Depositary. Any beneficial interest in one of the Global Notes that is
transferred to a Person who takes delivery in the form of an interest in a different Global Note will, upon transfer, cease to be an interest in such Global Note and become an interest in the other Global Note and, accordingly, will thereafter be
subject to all transfer restrictions, if any, and other procedures applicable to beneficial interests in such other Global Note for as long as it remains such an interest. A transferor of a beneficial interest in a Global Note shall deliver to the
Registrar a written order given in accordance with the Depositary’s Applicable Procedures containing information regarding the participant account of the Depositary to be credited with a beneficial interest in the relevant Global Note. The
Registrar shall, in accordance with such instructions, instruct the Depositary to credit to the account of the Person specified in such instructions a beneficial interest in such Global Note and to debit the account of the Person making the transfer
the beneficial interest in the Global Note being transferred. 
 Section 1.10.    Satisfaction and Discharge of
Indenture. This Section 1.10 shall replace Section 9.01(a) of the Base Indenture with respect to the Notes only. 

(a)    either (i) all the Notes of such series that have been authenticated and delivered have been cancelled or
delivered to the Trustee for cancellation (other than any Notes of such series which shall have been destroyed, lost or stolen and which shall have been replaced or paid as provided in Section 2.09 of the Base Indenture); or (ii) all the
Notes of such series issued that have not been cancelled or delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and payable at their final maturity within one year, or are to be called for
redemption within one year under irrevocable arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the Company’s name and at the Company’s expense, and the Company shall have irrevocably
deposited or caused to be deposited with the Trustee sufficient funds to pay and discharge the entire indebtedness on the applicable Notes to pay principal, interest, if any, and any premium, which for purposes of this provision shall be calculated
without applying any “present value discount” and using a Treasury Rate of no less than zero. 

Section 1.11.    Successors. Upon any consolidation or merger, or any sale, transfer, lease, conveyance or
other disposition of the assets of the Company substantially as an entirety in a transaction that is subject to, and that complies with the provisions of, Article 8 of the Base Indenture, the successor Person formed by such consolidation or into or
with which the Company is merged or to which such sale, lease, transfer, conveyance or other disposition is made shall succeed to, and be substituted for (so that from and after the date of such consolidation, merger, sale, lease, transfer,
conveyance or other disposition, the provisions of this Indenture referring to 

  
 18 

 
the “Company” shall refer instead to the successor Person and not to the Company), and may exercise every right and power of the Company under this Indenture with the same effect as if
such successor Person had been named as the Company herein; provided, however, that the predecessor Company shall not be relieved from the obligation to pay the principal of and interest on the Notes except in the case of a sale of all
of the Company’s assets in a transaction that is subject to, and that complies with the provisions of, this Section 1.11. 

ARTICLE 2 

MISCELLANEOUS 

Section 2.01.    Definitions. Capitalized terms used but not defined in this Supplemental Indenture shall have
the meanings ascribed thereto in the Base Indenture. 
 Section 2.02.    Confirmation of Indenture. The Base
Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects ratified and confirmed, and the Base Indenture, this Supplemental Indenture and all indentures supplemental thereto shall be read, taken and construed as one
and the same instrument. 
 Section 2.03.    Governing Law. THIS INDENTURE AND THE NOTES, INCLUDING ANY
CLAIM OR CONTROVERSY ARISING OUT OF OR RELATING TO THE INDENTURE OR THE NOTES, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF
THE STATE OF NEW YORK. 
 Section 2.04.    Severability. In case any provision in this Supplemental
Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 

Section 2.05.    Counterparts. This Supplemental Indenture may be executed in any number of counterparts and
by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 

Section 2.06.    No Benefit. Nothing in this Supplemental Indenture, express or implied, shall give to any
person other than the parties hereto and their successors or assigns, and the Holders of the Notes, any benefit or legal or equitable rights, remedy or claim under this Supplemental Indenture or the Base Indenture. 

Section 2.07.    Trustee. The Trustee makes no representations or warranties as to the validity or sufficiency
of this Supplemental Indenture. 
 Section 2.08.    Electronic Signatures. The Trustee shall have the right
to accept and act upon any notice, instruction, or other communication, including any funds transfer instruction (each, a “Notice”), received pursuant to this Indenture by electronic transmission (including by e-mail, facsimile transmission, web portal or other electronic methods) and shall not have any duty to confirm that the person sending such Notice is, in fact, a person authorized to do so. Electronic signatures
believed by the Trustee to comply with the ESIGN Act of 2000 or other applicable law (including electronic images of handwritten signatures and digital signatures provided by DocuSign, Orbit, Adobe Sign or any other digital signature provider
identified by any other party hereto and acceptable to the Trustee) shall be deemed original signatures for all purposes. Each 

  
 19 

 
other party to this Indenture assumes all risks arising out of the use of electronic signatures and electronic methods to send Notices to the Trustee, including without limitation the risk of the
Trustee acting on an unauthorized Notice and the risk of interception or misuse by third parties. Notwithstanding the foregoing, the Trustee may in any instance and in its sole discretion require that a Notice in the form of an original document
bearing a manual signature be delivered to the Trustee in lieu of, or in addition to, any such electronic Notice. 
 [Signature pages
follow.] 

  
 20 

 IN WITNESS WHEREOF, the parties hereto have caused the Indenture to be duly executed as of
the date set forth above. 
  

					
	DXC TECHNOLOGY COMPANY
		
	By:	 	 /s/ Kenneth P. Sharp

		 	Name:	 	Kenneth P. Sharp
		 	Title:	 	Executive Vice President and Chief Financial Officer
		
	By:	 	 /s/ Ceyhun Cetin

		 	Name:	 	Ceyhun Cetin
		 	Title:	 	Vice President and Treasurer

  
 [Signature Page to
Supplemental Indenture] 

 
			
	 U.S. BANK NATIONAL ASSOCIATION,

as Trustee

		
	By:	 	 /s/ Elizabeth A. Boyd

		 	Name:  Elizabeth A. Boyd
		 	Title:    Vice President

  
 [Signature Page to
Supplemental Indenture] 

 EXHIBIT A 

FORM OF GLOBAL NOTE 

[Global Notes Legend] 
 THIS
SECURITY IS A REGISTERED GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITORY OR A NOMINEE OF A DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A
PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE DEPOSITARY TO THE
DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH A SUCCESSOR DEPOSITARY. 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER
ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST
HEREIN. 

  
 A-1 

 FORM OF 1.800% SENIOR NOTES DUE 2026 

 

			
	No. [            ]	  	$[        ]

 CUSIP No. 23355L AL0 

DXC TECHNOLOGY COMPANY 

DXC TECHNOLOGY COMPANY (F.K.A. EVERETT SPINCO, INC.), a Nevada corporation (the “Company”), promises to pay to
[Cede & Co.]1 or registered assigns the principal sum of [                    ] Dollars
($[        ]) [(subject to the decreases and increases in principal amount set forth on the Schedule of Exchanges of Interests in the Global Note attached
hereto)]2 on September 15, 2026. 
 Interest Payment Dates: March 15 and September 15
(the “Interest Payment Dates”), commencing March 15, 2022. 
 Record Dates: 15 calendar days prior to each Interest Payment Date (the
“Record Dates”). 
 Each holder of this Note (as defined below), by accepting the same, agrees to and shall be bound by the
provisions hereof and of the Indenture described herein, and authorizes and directs the Trustee described herein on such holder’s behalf to be bound by such provisions. Each holder of this Note hereby waives all notice of the acceptance of the
provisions contained herein and in the Indenture and waives reliance by such holder upon said provisions. 
 This Note shall not be entitled
to any benefit under the Indenture, or be valid or become obligatory for any purpose, until the Certificate of Authentication hereon shall have been manually signed by or on behalf of the Trustee. The provisions of this Note are continued on the
reverse side hereof, and such continued provisions shall for all purposes have the same effect as though fully set forth at this place. 
  

 

	1 	 Insert for Global Notes only. 

	2 	 Insert for Global Notes only. 

  
 A-2 

 IN WITNESS WHEREOF, the Company has caused this Note to be signed in accordance with the
Indenture. 
 Date: [            ], [        ] 

 

					
	DXC TECHNOLOGY COMPANY
		
	By:	 	     

		 	Name:	 	Kenneth P. Sharp
		 	Title:	 	 Executive Vice President and Chief
 Financial
Officer

		
	By:	 	     

		 	Name:	 	Ceyhun Cetin
		 	Title:	 	Vice President and Treasurer

  
 A-3 

 CERTIFICATE OF AUTHENTICATION 

This is one of the 1.800% Senior Notes due 2026 issued by DXC Technology Company of the series designated therein referred to in the
within-mentioned Indenture. 
 Date: [            ],
[        ] 
  

			
	 U.S. BANK NATIONAL ASSOCIATION

as Trustee

		
	By:	 	     

		 	Name:  Elizabeth A. Boyd
		 	Title:    Vice President

  
 A-4 

 DXC Technology Company 

1.800% Senior Notes due 2026 

This note is one of a duly authorized series of debt securities of DXC Technology Company (f.k.a. Everett SpinCo, Inc.), a Nevada corporation
(the “Company”), issued or to be issued in one or more series under and pursuant to an indenture for the Company’s debentures, notes or other debt instruments evidencing its Indebtedness, dated as of March 27, 2017 (the
“Base Indenture”), duly executed and delivered by and between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by the Ninth Supplemental Indenture, dated as of
September 9, 2021 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company and the Trustee. By the terms of the Base Indenture, the debt securities issuable
thereunder are issuable in series that may vary as to amount, date of maturity, rate of interest and in other respects as provided in the Base Indenture. This note is one of the series designated on the face hereof (individually, a
“Note,” and collectively, the “Notes”), and reference is hereby made to the Indenture for a description of the rights, limitations of rights, obligations, duties and immunities of the Trustee, the Company and the
Holders of the Notes (the “Holders”). Capitalized terms used herein and not otherwise defined shall have the meanings given them in the Base Indenture or the Supplemental Indenture, as applicable. 

1.    Interest. The rate at which the Notes shall bear interest shall be 1.800% per year. [The date from which
interest shall accrue on the Notes shall be September 9, 2021 or the most recent Interest Payment Date to which interest has been paid or provided for.]3 [Interest on this Note will accrue
(or will be deemed to have accrued) from the most recent date to which interest on this Note or any of its predecessor Notes has been paid or duly provided for or, if no such interest has been paid, from
            ,         .]4 The Interest Payment Dates for the Notes shall be March 15 and
September 15 of each year, beginning March 15, 2022. Interest shall be payable on each Interest Payment Date to the Holders of record at the close of business on the 15th calendar day prior to each Interest Payment Date. The basis upon
which interest shall be calculated shall be that of a 360-day year consisting of twelve 30-day months. 

2.    Method of Payment. The Company will pay interest on the Notes (except defaulted interest), if any, to the
persons in whose name such Notes are registered at the close of business on the regular record date referred to on the facing page of this Note for such interest installment. In the event that the Notes or a portion thereof are called for redemption
and the Redemption Date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Notes will be paid upon presentation and surrender of such Notes as provided in the
Indenture. The principal of and the interest on the Notes shall be payable in Dollars at the office or agency of the Company maintained for that purpose in accordance with the Indenture. 

3.    Paying Agent and Registrar. Initially, the Trustee will act as paying agent and Registrar. The Company may
change or appoint any paying agent or Registrar without notice to any Holder. 
  

 

	3	 Include for Initial Notes only. 

	4 	 Include for Additional Notes only. 

  
 A-5 

 4.    Indenture. The terms of the Notes include those stated in
the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (“Trust Indenture Act”) as in effect on the date the Indenture is qualified. The Notes are subject to all such terms, and Holders are
referred to the Indenture and the Trust Indenture Act for a statement of such terms. The Notes are senior unsecured obligations of the Company and constitute the series designated on the face hereof as the “1.800% Senior Notes due 2026”,
initially limited to $700,000,000 in aggregate principal amount. The Company will furnish to any Holders upon written request and without charge a copy of the Base Indenture and the Supplemental Indenture. Requests may be made to: DXC Technology
Company, 1775 Tysons Boulevard, Tysons, Virginia 22102, Attention: General Counsel. 
 5.    Redemption. The
Notes shall be redeemable, in whole or in part, at the Company’s option, at any time and from time to time, as provided in Section 1.05 of the Supplemental Indenture. Unless the Company defaults in payment of the Redemption Price, on and
after any Redemption Date for the Notes, interest shall cease to accrue on the Notes or portions thereof called for redemption. 

6.    Mandatory Redemption or Sinking Fund. The Company is not required to make mandatory redemption or sinking
fund payments with respect to the Notes. 
 7.    Change of Control Triggering Event. If a Change of Control
Triggering Event occurs with respect to the Notes, unless the Company has redeemed such Notes as described in Section 1.05 of the Supplemental Indenture, the Company will make an offer to each Holder of such Notes to repurchase all or any part
(equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that Holder’s Notes at a repurchase price, payable in cash, equal to 101.0% of the aggregate principal amount of Notes repurchased, plus accrued and unpaid interest, on
the Notes repurchased to, but excluding, the date of repurchase. Within 30 days following any Change of Control Triggering Event or, at the Company’s option, prior to any Change of Control, but after public announcement of the transaction that
constitutes or may constitute the Change of Control, a notice will be sent to Holders of the Notes, with a copy to the Trustee, describing the transaction that constitutes or may constitute the Change of Control Triggering Event and offering to
repurchase such Notes on the date specified in the notice, which date will be no earlier than 10 days and no later than 90 days from the date such notice is mailed, in accordance with Section 1.07(d) of the Supplemental Indenture. 

8.    Denominations, Transfer, Exchange. The Notes are in registered form without coupons in minimum denominations
of $2,000 or an integral multiple of $1,000 in excess thereof. The transfer of Notes may be registered and Notes may be exchanged as provided in Section 1.04 and Section 1.09 of the Supplemental Indenture and Section 2.08 and
Section 2.09 of the Base Indenture. The Notes may be presented for exchange or for registration of transfer at the office of the Company or its agency designated by the Company for such purpose. 

9.    Persons Deemed Owners. The person in whose name this Note is registered may be treated as its owner for all
purposes. 
 10.    Repayment to the Company. The Trustee and the paying agent shall pay to the Company upon
request any money held by them for the payment of principal and interest that remains unclaimed for two years. After that, Holders entitled to the money must look to the Company for payment as general creditors unless an applicable abandoned
property law designates another person. 

  
 A-6 

 11.    Amendments, Supplements and Waivers. Subject to certain
exceptions, the Company and the Trustee may amend or supplement the Indenture and the Notes with the written consent (including consents obtained in connection with a tender offer or exchange offer for Notes) of the Holders of a majority in
principal amount of the then outstanding Notes, and compliance with any provision of the Indenture and the Notes may be waived with the written consent (including consents obtained in connection with a tender offer or exchange offer for Notes) of
the Holders of a majority in principal amount of the then outstanding Notes. The Company and the Trustee may amend or supplement the Indenture and the Notes without notice to or consent of any Holder as provided in the Indenture, including, without
limitation, to maintain the qualification of the Indenture under the Trust Indenture Act or to cure any ambiguity, defect or inconsistency or make any change that would not adversely affect the legal rights under the Indenture of any Holder in any
material respect. 
 12.    Defaults and Remedies. If an Event of Default with respect to the Notes occurs and is
continuing (other than an Event of Default in Section 1.08(a)(v) or Section 1.08(a)(vi) of the Supplemental Indenture), then in every such case the Trustee or the Holders of not less than 25.0% in principal amount of the Outstanding Notes
may declare the principal amount of and accrued and unpaid interest, if any, on all the Notes to be due and payable immediately, by a notice in writing to the Company (and to the Trustee if given by the Holders), and upon such declaration such
principal amount and accrued and unpaid interest, if any, shall become immediately due and payable. If an Event of Default specified in Section 1.08(a)(v) or Section 1.08(a)(vi) of the Supplemental Indenture shall occur, the principal of
and accrued and unpaid interest, if any, on all Outstanding Notes shall ipso facto become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holder of Outstanding Notes. Subject to the
terms of the Indenture, if an Event of Default under the Indenture shall occur and be continuing, the Trustee will be under no obligation to exercise any of the rights or powers vested in it by the Indenture at the request or direction of any of the
Holders unless such Holders shall have offered the Trustee security or indemnity satisfactory to it. Upon satisfaction of certain conditions set forth in the Indenture, the Holders of a majority in principal amount of the Outstanding Notes shall
have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Notes. 

13.    Trustee May Hold Securities. The Trustee, subject to certain limitations imposed by the Trust Indenture Act,
in its individual or any other capacity, may become the owner or pledgee of Notes with the same rights it would have if it were not Trustee, paying agent or Registrar. 

14.    No Recourse Against Others. A director, officer, employee or stockholder (past or present), as such, of the
Company shall not have any liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. Each Holder by accepting a Note waives and releases
all such liability. The waiver and release are part of the consideration for the issue of the Notes. 

15.    Discharge of Indenture. The Indenture contains certain provisions pertaining to discharge and defeasance,
which provisions shall for all purposes have the same effect as if set forth herein. 
 16.    Authentication.
This Note shall not be valid until the Trustee manually signs the certificate of authentication attached to the other side of this Note. 

  
 A-7 

 17.    Trust Indenture Act Controls. This Indenture incorporates
and is governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act. If any provision of this Indenture limits, qualifies or conflicts with the duties imposed
by the Trust Indenture Act, the imposed duties shall control. 
 18.    Abbreviations. Customary abbreviations
may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (=
Uniform Gifts to Minors Act). 
 19.    Governing Law. THE INDENTURE AND THIS NOTE, INCLUDING ANY CLAIM OR
CONTROVERSY ARISING OUT OF OR RELATING TO THE INDENTURE OR THIS NOTE, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE
OF NEW YORK. 

  
 A-8 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: (I) or (we) assign and transfer this Note to: 

 

                          
                                         
          
 (Insert assignee’s legal name 

 

	
	  

	(Insert assignee’s soc. sec. or tax I.D. no.)
	
	  

	
	  

	
	  

	
	  

	(Print or type assignee’s name, address and zip code)

 and irrevocably appoint
                                         
                                         
                                         
                                         
     agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 
 Date:
                     
  

	
	Your                                     
                                         
   
	Signature:
	(Sign exactly as your name appears on the face of this Note)

  

			
	Signature
	Guarantee:	 	(Signature must be guaranteed by a participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee))

  
 A-9 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Company pursuant to Section 1.07(d) of the Supplemental Indenture, check the box:

  

	 	☐	 1.07(d) Change of Control Triggering Event 

If you want to elect to have only part of this Note purchased by the Company pursuant to Section 1.07(d) of the Supplemental Indenture,
state the amount: $[        ]. 
 Date:
                     
  

	
	Your                                     
                                         
   
	Signature:
	(Sign exactly as your name appears on the other side of this Note)
	
	Tax I.D. Number                                  
                           

 

	
	Signature
	Guarantee:                                    
                                 
	(Signature must be guaranteed by a participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee))

  
 A-10 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE 

The following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Security, or exchanges of a
part of another Global Note or Definitive Security for an interest in this Global Note, have been made: 
  

															
	 Date of Exchange
	  	Amount of
decrease in
Principal Amount
of this Global
Note	 	  	Amount of
increase in
Principal Amount
of this Global
Note	 	  	Principal Amount
of this Global
Note following
such decrease (or
increase)	 	  	 Signature of

authorized officer
 of
Trustee or
 custodian

		  				  				  				  	
		  				  				  				  	
		  				  				  				  	

  
 A-11 

 EXHIBIT B 

FORM OF GLOBAL NOTE 

[Global Notes Legend] 
 THIS
SECURITY IS A REGISTERED GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITORY OR A NOMINEE OF A DEPOSITARY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A
PERSON OTHER THAN THE DEPOSITARY OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, BY A NOMINEE OF THE DEPOSITARY TO THE
DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH A SUCCESSOR DEPOSITARY. 

UNLESS THIS SECURITY IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER,
EXCHANGE OR PAYMENT, AND ANY SECURITY ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER
ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST
HEREIN. 

  
 B-1 

 FORM OF 2.375% SENIOR NOTES DUE 2028 

 

			
	No. [            ]	  	$[        ]

 CUSIP No. 23355L AM8 

DXC TECHNOLOGY COMPANY 

DXC TECHNOLOGY COMPANY (F.K.A. EVERETT SPINCO, INC.), a Nevada corporation (the “Company”), promises to pay to
[Cede & Co.]5 or registered assigns the principal sum of [                    ] Dollars
($[        ]) [(subject to the decreases and increases in principal amount set forth on the Schedule of Exchanges of Interests in the Global Note attached
hereto)]6 on September 15, 2028. 
 Interest Payment Dates: March 15 and September 15
(the “Interest Payment Dates”), commencing March 15, 2022. 
 Record Dates: 15 calendar days prior to each Interest Payment Date (the
“Record Dates”). 
 Each holder of this Note (as defined below), by accepting the same, agrees to and shall be bound by the
provisions hereof and of the Indenture described herein, and authorizes and directs the Trustee described herein on such holder’s behalf to be bound by such provisions. Each holder of this Note hereby waives all notice of the acceptance of the
provisions contained herein and in the Indenture and waives reliance by such holder upon said provisions. 
 This Note shall not be entitled
to any benefit under the Indenture, or be valid or become obligatory for any purpose, until the Certificate of Authentication hereon shall have been manually signed by or on behalf of the Trustee. The provisions of this Note are continued on the
reverse side hereof, and such continued provisions shall for all purposes have the same effect as though fully set forth at this place. 
  

 

	5 	 Insert for Global Notes only. 

	6 	 Insert for Global Notes only. 

  
 B-2 

 IN WITNESS WHEREOF, the Company has caused this Note to be signed in accordance with the
Indenture. 
 Date: [            ], [        ] 

 

					
	DXC TECHNOLOGY COMPANY
		
	By:	 	     

		 	Name:	 	 Kenneth P. Sharp

		 	Title:	 	 Executive Vice President and Chief

Financial Officer

		
	By:	 	     

		 	Name:	 	 Ceyhun Cetin

		 	Title:	 	 Vice President and Treasurer

  
 B-3 

 CERTIFICATE OF AUTHENTICATION 

This is one of the 2.375% Senior Notes due 2028 issued by DXC Technology Company of the series designated therein referred to in the
within-mentioned Indenture. 
 Date: [            ],
[        ] 
  

			
	 U.S. BANK NATIONAL ASSOCIATION

as Trustee

		
	By:	 	     

		 	Name:  Elizabeth A. Boyd
		 	Title:    Vice President

  
 B-4 

 DXC Technology Company 

2.375% Senior Notes due 2028 

This note is one of a duly authorized series of debt securities of DXC Technology Company (f.k.a. Everett SpinCo, Inc.), a Nevada corporation
(the “Company”), issued or to be issued in one or more series under and pursuant to an indenture for the Company’s debentures, notes or other debt instruments evidencing its Indebtedness, dated as of March 27, 2017 (the
“Base Indenture”), duly executed and delivered by and between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by the Ninth Supplemental Indenture, dated as of
September 9, 2021 (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), between the Company and the Trustee. By the terms of the Base Indenture, the debt securities issuable
thereunder are issuable in series that may vary as to amount, date of maturity, rate of interest and in other respects as provided in the Base Indenture. This note is one of the series designated on the face hereof (individually, a
“Note,” and collectively, the “Notes”), and reference is hereby made to the Indenture for a description of the rights, limitations of rights, obligations, duties and immunities of the Trustee, the Company and the
Holders of the Notes (the “Holders”). Capitalized terms used herein and not otherwise defined shall have the meanings given them in the Base Indenture or the Supplemental Indenture, as applicable. 

1.    Interest. The rate at which the Notes shall bear interest shall be 2.375% per year. [The date from which
interest shall accrue on the Notes shall be September 9, 2021 or the most recent Interest Payment Date to which interest has been paid or provided for.]7 [Interest on this Note will accrue
(or will be deemed to have accrued) from the most recent date to which interest on this Note or any of its predecessor Notes has been paid or duly provided for or, if no such interest has been paid, from
            ,         .]8 The Interest Payment Dates for the Notes shall be March 15 and
September 15 of each year, beginning March 15, 2022. Interest shall be payable on each Interest Payment Date to the Holders of record at the close of business on the 15th calendar day prior to each Interest Payment Date. The basis upon
which interest shall be calculated shall be that of a 360-day year consisting of twelve 30-day months. 

2.    Method of Payment. The Company will pay interest on the Notes (except defaulted interest), if any, to the
persons in whose name such Notes are registered at the close of business on the regular record date referred to on the facing page of this Note for such interest installment. In the event that the Notes or a portion thereof are called for redemption
and the Redemption Date is subsequent to a regular record date with respect to any Interest Payment Date and prior to such Interest Payment Date, interest on such Notes will be paid upon presentation and surrender of such Notes as provided in the
Indenture. The principal of and the interest on the Notes shall be payable in Dollars at the office or agency of the Company maintained for that purpose in accordance with the Indenture. 

3.    Paying Agent and Registrar. Initially, the Trustee will act as paying agent and Registrar. The Company may
change or appoint any paying agent or Registrar without notice to any Holder. 
  

 

	7 	 Include for Initial Notes only. 

	8 	 Include for Additional Notes only. 

  
 B-5 

 4.    Indenture. The terms of the Notes include those stated in
the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (“Trust Indenture Act”) as in effect on the date the Indenture is qualified. The Notes are subject to all such terms, and Holders are
referred to the Indenture and the Trust Indenture Act for a statement of such terms. The Notes are senior unsecured obligations of the Company and constitute the series designated on the face hereof as the “2.375% Senior Notes due 2028”,
initially limited to $650,000,000 in aggregate principal amount. The Company will furnish to any Holders upon written request and without charge a copy of the Base Indenture and the Supplemental Indenture. Requests may be made to: DXC Technology
Company, 1775 Tysons Boulevard, Tysons, Virginia 22102, Attention: General Counsel. 
 5.    Redemption. The
Notes shall be redeemable, in whole or in part, at the Company’s option, at any time and from time to time, as provided in Section 1.05 of the Supplemental Indenture. Unless the Company defaults in payment of the Redemption Price, on and
after any Redemption Date for the Notes, interest shall cease to accrue on the Notes or portions thereof called for redemption. 

6.    Mandatory Redemption or Sinking Fund. The Company is not required to make mandatory redemption or sinking
fund payments with respect to the Notes. 
 7.    Change of Control Triggering Event. If a Change of Control
Triggering Event occurs with respect to the Notes, unless the Company has redeemed such Notes as described in Section 1.05 of the Supplemental Indenture, the Company will make an offer to each Holder of such Notes to repurchase all or any part
(equal to $2,000 or an integral multiple of $1,000 in excess thereof) of that Holder’s Notes at a repurchase price, payable in cash, equal to 101.0% of the aggregate principal amount of Notes repurchased, plus accrued and unpaid interest, on
the Notes repurchased to, but excluding, the date of repurchase. Within 30 days following any Change of Control Triggering Event or, at the Company’s option, prior to any Change of Control, but after public announcement of the transaction that
constitutes or may constitute the Change of Control, a notice will be sent to Holders of the Notes, with a copy to the Trustee, describing the transaction that constitutes or may constitute the Change of Control Triggering Event and offering to
repurchase such Notes on the date specified in the notice, which date will be no earlier than 10 days and no later than 90 days from the date such notice is mailed, in accordance with Section 1.07(d) of the Supplemental Indenture. 

8.    Denominations, Transfer, Exchange. The Notes are in registered form without coupons in minimum denominations
of $2,000 or an integral multiple of $1,000 in excess thereof. The transfer of Notes may be registered and Notes may be exchanged as provided in Section 1.04 and Section 1.09 of the Supplemental Indenture and Section 2.08 and
Section 2.09 of the Base Indenture. The Notes may be presented for exchange or for registration of transfer at the office of the Company or its agency designated by the Company for such purpose. 

9.    Persons Deemed Owners. The person in whose name this Note is registered may be treated as its owner for all
purposes. 
 10.    Repayment to the Company. The Trustee and the paying agent shall pay to the Company upon
request any money held by them for the payment of principal and interest that remains unclaimed for two years. After that, Holders entitled to the money must look to the Company for payment as general creditors unless an applicable abandoned
property law designates another person. 

  
 B-6 

 11.    Amendments, Supplements and Waivers. Subject to certain
exceptions, the Company and the Trustee may amend or supplement the Indenture and the Notes with the written consent (including consents obtained in connection with a tender offer or exchange offer for Notes) of the Holders of a majority in
principal amount of the then outstanding Notes, and compliance with any provision of the Indenture and the Notes may be waived with the written consent (including consents obtained in connection with a tender offer or exchange offer for Notes) of
the Holders of a majority in principal amount of the then outstanding Notes. The Company and the Trustee may amend or supplement the Indenture and the Notes without notice to or consent of any Holder as provided in the Indenture, including, without
limitation, to maintain the qualification of the Indenture under the Trust Indenture Act or to cure any ambiguity, defect or inconsistency or make any change that would not adversely affect the legal rights under the Indenture of any Holder in any
material respect. 
 12.    Defaults and Remedies. If an Event of Default with respect to the Notes occurs and is
continuing (other than an Event of Default in Section 1.08(a)(v) or Section 1.08(a)(vi) of the Supplemental Indenture), then in every such case the Trustee or the Holders of not less than 25.0% in principal amount of the Outstanding Notes
may declare the principal amount of and accrued and unpaid interest, if any, on all the Notes to be due and payable immediately, by a notice in writing to the Company (and to the Trustee if given by the Holders), and upon such declaration such
principal amount and accrued and unpaid interest, if any, shall become immediately due and payable. If an Event of Default specified in Section 1.08(a)(v) or Section 1.08(a)(vi) of the Supplemental Indenture shall occur, the principal of
and accrued and unpaid interest, if any, on all Outstanding Notes shall ipso facto become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holder of Outstanding Notes. Subject to the
terms of the Indenture, if an Event of Default under the Indenture shall occur and be continuing, the Trustee will be under no obligation to exercise any of the rights or powers vested in it by the Indenture at the request or direction of any of the
Holders unless such Holders shall have offered the Trustee security or indemnity satisfactory to it. Upon satisfaction of certain conditions set forth in the Indenture, the Holders of a majority in principal amount of the Outstanding Notes shall
have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Notes. 

13.    Trustee May Hold Securities. The Trustee, subject to certain limitations imposed by the Trust Indenture Act,
in its individual or any other capacity, may become the owner or pledgee of Notes with the same rights it would have if it were not Trustee, paying agent or Registrar. 

14.    No Recourse Against Others. A director, officer, employee or stockholder (past or present), as such, of the
Company shall not have any liability for any obligations of the Company under the Notes or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. Each Holder by accepting a Note waives and releases
all such liability. The waiver and release are part of the consideration for the issue of the Notes. 

15.    Discharge of Indenture. The Indenture contains certain provisions pertaining to discharge and defeasance,
which provisions shall for all purposes have the same effect as if set forth herein. 
 16.    Authentication.
This Note shall not be valid until the Trustee manually signs the certificate of authentication attached to the other side of this Note. 

  
 B-7 

 17.    Trust Indenture Act Controls. This Indenture incorporates
and is governed by the provisions of the Trust Indenture Act that are required to be part of and to govern indentures qualified under the Trust Indenture Act. If any provision of this Indenture limits, qualifies or conflicts with the duties imposed
by the Trust Indenture Act, the imposed duties shall control. 
 18.    Abbreviations. Customary abbreviations
may be used in the name of a Holder or an assignee, such as: TEN COM (= tenants in common), TEN ENT (= tenants by the entireties), JT TEN (= joint tenants with right of survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (=
Uniform Gifts to Minors Act). 
 19.    Governing Law. THE INDENTURE AND THIS NOTE, INCLUDING ANY CLAIM OR
CONTROVERSY ARISING OUT OF OR RELATING TO THE INDENTURE OR THIS NOTE, SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE
OF NEW YORK. 

  
 B-8 

 ASSIGNMENT FORM 

To assign this Note, fill in the form below: (I) or (we) assign and transfer this Note to: 

 

                          
                                         
              
 (Insert assignee’s legal name 

 

	
	  

	(Insert assignee’s soc. sec. or tax I.D. no.)
	
	  

	
	  

	
	  

	
	  

	(Print or type assignee’s name, address and zip code)

 and irrevocably appoint
                                         
                                         
                                         
                                         
             agent to transfer this Note on the books of the Company. The agent may substitute another to act for him. 

Date:                      

 

	
	Your                                     
                                         

	Signature:
	(Sign exactly as your name appears on the face of this Note)

  

			
	Signature
	Guarantee:	 	(Signature must be guaranteed by a participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee))

  
 B-9 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Note purchased by the Company pursuant to Section 1.07(d) of the Supplemental Indenture, check the box:

  

	 	☐	 1.07(d) Change of Control Triggering Event 

If you want to elect to have only part of this Note purchased by the Company pursuant to Section 1.07(d) of the Supplemental Indenture,
state the amount: $[        ]. 
 Date:
                     
  

	
	Your                                     
                                         
   
	Signature:
	(Sign exactly as your name appears on the other side of this
	Note)
	
	Tax I.D. Number                                  
                           

 

			
	Signature
	Guarantee:	 	                                      
                                      
	(Signature must be guaranteed by a participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee))

  
 B-10 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE 

The following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Security, or exchanges of a
part of another Global Note or Definitive Security for an interest in this Global Note, have been made: 
  

															
	 Date of Exchange
	  	Amount of
decrease in
Principal Amount
of this Global
Note	 	  	Amount of
increase in
Principal Amount
of this Global
Note	 	  	Principal Amount
of this Global
Note following
such decrease (or
increase)	 	  	 Signature of

authorized officer
 of
Trustee or
 custodian

		  				  				  				  	
		  				  				  				  	
		  				  				  				  	

  
 B-11Exhibit 10.1

      

    

     

    

    Confidential

     

    

    
      SUBSCRIPTION AGREEMENT

       

      Highland Transcend Partners I Corp.

      777 Arthur Godfrey Road, #202

      Miami Beach, FL 33140

      

      

      Ladies and Gentlemen:

       

      This Subscription Agreement (this “Subscription Agreement”) is being entered into as of the date set forth on the signature page hereto, by and between Highland Transcend Partners I Corp., a
        Cayman Islands exempted company (including any successor thereto pursuant to the terms of the Transaction Agreement (as defined below), “Highland Transcend”), and the undersigned investor (the “Investor”), in connection with the
        proposed business combination (as further described in the Transaction Agreement, the “Transaction”) between Highland Transcend and Packable Holdings, LLC, a limited liability company incorporated under the laws of Delaware (the “Company”),

        pursuant to the Business Combination Agreement (as may be amended, supplemented or otherwise modified from time to time, the “Transaction Agreement”) to be entered into by and among Highland Transcend, the Company, CP VII Pacer Corp., a
        Delaware corporation and CP VII Pacer EU L.P., a Delaware limited partnership, pursuant to which, among other things Highland Transcend will acquire common units of the Company. Prior to the closing of the Transaction (and as more fully described
        in the Transaction Agreement), Highland Transcend will domesticate as a Delaware corporation in accordance with Section 388 of the General Corporation Law of the State of Delaware and Part XII of the Cayman Islands Companies Law (2020 Revision)
        (the “Domestication”).

       

      Highland Transcend is seeking commitments from interested investors to purchase after the Domestication shares of
        the common stock of Highland Transcend, par value of $0.0001 per share (the “Shares”), for a purchase price of $10.00 per share (the “Per Share Price”). The
        aggregate purchase price to be paid by the Investor for the subscribed Shares (as set forth on the signature page hereto) is referred to herein as the “Subscription Amount.” On or about the date of this Subscription Agreement Highland
        Transcend is entering into subscription agreements (the “Other Subscription Agreements”) with certain other investors (the “Other Investors” and together the Investor, the “Investors”), pursuant to which such Investors have
        agreed to purchase on the closing date of the Transaction, inclusive of the Shares subscribed for herein, an aggregate amount of not less than 7,000,000 Shares, at a price of $10.00 per Share.

       

      For ease of administration, this single Subscription Agreement is being executed so as to enable each Investor identified on the signature page to enter into a Subscription Agreement, severally,
        but not jointly. The parties agree that the Subscription Agreement shall be treated as if it were a separate agreement with respect to each Investor listed on the signature page, as if each Investor entity had executed a separate Subscription
        Agreement naming only itself as Investor.

       

      In connection therewith, and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth herein, and intending to be legally
        bound hereby, the Investor and Highland Transcend agree as follows:

       

      1.           Subscription. The Investor hereby subscribes for and agrees to purchase from Highland Transcend, and Highland Transcend agrees to issue and sell to the Investor, the number of
        Shares as is set forth on the signature page of this Subscription Agreement on the terms and conditions provided for herein. The Investor acknowledges and agrees that, as a result of the Domestication, the Shares that will be purchased by the
        Investor and issued by Highland Transcend pursuant hereto shall be shares of common stock in a Delaware corporation (and not, for the avoidance of doubt, ordinary shares in a Cayman Islands exempted company). Notwithstanding the foregoing or
        anything to the contrary in Section 10 below, in the event that the Transaction Agreement is terminated in accordance with its terms, this Subscription Agreement
        shall be void and of no further effect and any monies paid by the Investor to Highland Transcend in connection herewith shall immediately be returned to the Investor.

       

      
        
          

        
          Confidential

        

      

      
      2.           Closing. The closing of the purchase and sale of the Shares contemplated hereby (the “Closing”)
        is contingent upon the substantially concurrent consummation of the Transaction. The Closing shall occur on the date of, and immediately following the consummation of, and conditioned upon the effectiveness of, the Transaction. Upon delivery of
        written notice from (or on behalf of) Highland Transcend to the Investor (the “Closing Notice”), that Highland Transcend reasonably expects the closing of the
        Transaction to occur on a specified date that is not less than five (5) business days after the date on which the Closing Notice is delivered to the Investor (the “Closing

          Date”), the Investor shall deliver to Highland Transcend the Subscription Amount (i) not less than two (2) business days prior to the Closing Date, by wire transfer of United States dollars in immediately available funds to the account(s)
        specified by Highland Transcend in the Closing Notice, to be held in escrow until the Closing, or (ii) to the account(s) specified by Highland Transcend in the Closing Notice and as otherwise mutually agreed by the Investor and Highland Transcend
        (“Alternative Settlement Procedures”). For the avoidance of doubt, mutually agreeable Alternative Settlement Procedures shall include, without limitation, the Investor delivering to Highland Transcend on the Closing Date the Subscription
        Amount for the Shares by wire transfer of U.S. dollars in immediately available funds to the account(s) specified by Highland Transcend in the Closing Notice against delivery to the Investor of the Shares set forth on the signature page of the
        Investor to this Subscription Agreement. On the Closing Date, Highland Transcend shall issue to the Investor (or the funds and accounts designated by the Investor if so designated by the Investor, or its nominee in accordance with its delivery
        instructions) or to a custodian designated by the Investor, as applicable, the subscribed Shares set forth on the signature page of the Investor to this Subscription Agreement, free and clear of any liens or other restrictions whatsoever (other
        than those arising under state or federal securities laws), which Shares, unless otherwise determined by the Investor, shall be uncertificated, with record ownership reflected only in the register of shareholders of Highland Transcend and shall,
        prior to the delivering the funds on the Closing Date as provided in clause (i), provide evidence of such issuance from Highland Transcend’s transfer agent (the “Transfer Agent”) showing the Investor as the owner of the Shares on and as of
        the Closing Date. For purposes of this Subscription Agreement, “business day” shall mean any day other than (i) any Saturday or Sunday or (ii) any other day on which banks located in New York, New York are required or authorized by applicable law
        to be closed for business.

       

      3.           Closing Conditions.

       

      a.           The obligation of the parties hereto to consummate the purchase and sale of the Shares pursuant to this Subscription Agreement is subject to
        the satisfaction or waiver in writing by each party of the following conditions:

       

      (i)           no applicable governmental authority shall have enacted, issued, promulgated or entered any judgment, order, law, rule or
        regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions contemplated
        hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby, and no such governmental authority shall have
        instituted or threatened in writing a proceeding seeking to impose any such restraint or prohibition; and

       

      (ii)          all conditions precedent to the closing of
        the Transaction of the Transaction Agreement (other than those conditions which, by their nature, are to be satisfied at the closing of the Transaction) shall have been
        satisfied (as determined by the parties to the Transaction Agreement) or waived, and the Transaction shall have been consummated.

       

      b.           The obligation of Highland Transcend to consummate the purchase and sale of the Shares at the Closing pursuant to this Subscription Agreement
        shall be subject to the satisfaction or waiver by Highland Transcend of the additional conditions that:

       

      (i)           all representations and warranties of the Investor contained in this Subscription Agreement shall be true and correct at
        and as of the Closing Date in all material respects (other than representations and warranties that are qualified as to materiality, which representations and warranties shall be true and correct in all respects) at and as of the Closing Date
        (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects (other than representations and warranties
        that are qualified as to materiality, which representations and warranties shall be true and correct in all respects) as of such earlier date), and consummation of the Closing shall constitute a reaffirmation by the Investor of each of the
        representations, warranties, covenants and agreements of the Investor contained in this Subscription Agreement as of the Closing Date, or as of such earlier date, as applicable; and

       

      
        2

        
          

        
          Confidential

        

      

      (ii)          the Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements and
        conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing.

       

      c.          The obligation of the Investor to consummate the purchase and sale of the Shares at the Closing pursuant to this Subscription Agreement shall
        be subject to the satisfaction or waiver in writing by the Investor of the additional conditions (and the consummation of the Closing shall constitute a certification by Highland Transcend to the Investor that, to extent not waived in writing by
        the Investor, the conditions to Closing set forth in Sections 3(a) and 3(c) have been satisfied) that:

       

      (i)           all representations and warranties of Highland Transcend contained in this Subscription Agreement shall be true and
        correct as of the date made (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and warranty shall be true and correct as of such earlier date) and shall be true
        and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse
        Effect (as defined below), which representations and warranties shall be true and correct in all respects) at and as of the Closing Date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in
        which case such representation and warranty shall be true and correct in all material respects (other than representations and warranties that are qualified as to materiality or Material Adverse Effect (as defined below), which representations and
        warranties shall be true and correct in all respects) as of such earlier date), and consummation of the Closing shall constitute a reaffirmation by Highland Transcend of each of the representations, warranties, covenants and agreements of Highland
        Transcend contained in this Subscription Agreement as of the Closing Date or as of such earlier date, as applicable;

       

      (ii)          Highland Transcend shall have performed, satisfied and complied in all material respects with all covenants, agreements
        and conditions required by this Subscription Agreement to be performed, satisfied or complied with by it at or prior to the Closing;

       

      (iii)         no suspension of the qualification of the Shares for offering or sale or trading by the Securities and Exchange Commission
        (the “SEC”) or under the NYSE marketplace rules, or initiation or threatening in writing of any proceedings for any of such purposes, shall have occurred, and the Shares shall have been approved for listing on the NYSE, subject to official
        notice of issuance.

       

      (iv)         no Material Adverse Effect (as defined in the Transaction Agreement) shall have occurred between the date hereof and the
        Closing Date;

       

      (v)         the Transaction Agreement (as the same exists on the date of this Subscription Agreement) shall not have been amended to,
        and there shall have been no waiver or modification to the Transaction Agreement (as the same exists on the date of this Subscription Agreement) that would, materially adversely affect the economic benefits that the Investor would reasonably expect
        to receive under this Subscription Agreement without having received the Investor’s prior written consent; and

       

      (vi)         no Other Subscription Agreement shall have been amended, modified or waived in any manner that materially benefits any
        Other Investor unless the Investor shall have been offered substantially similar benefits in writing.

       

      4.          Further Assurances. At or prior to the Closing, Highland Transcend and the Investor shall execute and deliver such additional documents and take such additional actions as the
        parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated by this Subscription Agreement.

       

      
        3

        
          

        
          Confidential

        

      

      5.           Highland Transcend Representations and Warranties. Highland Transcend represents and warrants to the Investor that:

       

      a.           Highland Transcend has been duly organized as an exempted company with limited liability and is in
        good standing with the Registrar of Companies under the laws of the Cayman Islands and, at the time of the Closing, shall be duly organized as a Delaware corporation and be in good standing under the laws of the state of Delaware, in each case with
        organizational power and authority to own, lease and operate its properties and conduct its business as presently conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

       

      b.          This Subscription Agreement has been duly authorized, executed and delivered by Highland Transcend and, assuming that this Subscription
        Agreement constitutes the valid and binding agreement of the other parties hereto, this Subscription Agreement constitutes a legal, valid and binding obligation of Highland Transcend, enforceable against Highland Transcend in accordance with its
        terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether
        considered at law or equity.

       

      c.           The execution, delivery and performance of this Subscription Agreement, including the issuance and sale of the Shares and the compliance by
        Highland Transcend with all of the provisions of this Subscription Agreement, and the consummation of the transactions contemplated herein will not conflict with
        or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or assets of Highland Transcend or any of
        its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Highland Transcend or any of its subsidiaries is a party or by which Highland Transcend
        or any of its subsidiaries is bound or to which any of the property or assets of Highland Transcend is subject that would reasonably be expected to have a material adverse effect on the business, properties, financial condition, stockholders’
        equity or results of operations of Highland Transcend and its subsidiaries, taken as a whole, or the validity of the Shares or the ability or legal authority of Highland Transcend to enter into and perform its obligations under this Subscription
        Agreement (a “Material Adverse Effect”); (ii) result in any violation of the provisions of the organizational documents of Highland
        Transcend; or (iii) result in any violation of any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over Highland Transcend, any of its subsidiaries or any of
        their respective its properties that would reasonably be expected to have a Material Adverse Effect.

       

      d.           Highland Transcend is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or
        registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization (including the New York Stock Exchange) or other person in connection with the execution, delivery and performance of this
        Subscription Agreement, other than (i) filings required by applicable state securities laws, (ii) the filing of the Registration Statement (as defined below) pursuant to Section 8 below, (iii) those required by the New York Stock Exchange,
        including with respect to obtaining shareholder approval, (iv) those required to consummate the Transaction as provided under the Transaction Agreement, and (v) those the failure of which to obtain would not be reasonably expected to have a
        Material Adverse Effect.

       

      e.          Highland Transcend is not in default or violation (and no event has occurred which, with notice or the lapse of time or both, would constitute
        a default or violation) of any term, condition or provision of its organizational documents of Highland Transcend. Neither Highland Transcend nor any of its subsidiaries is in default or violation (and no event has occurred which, with notice or
        the lapse of time or both, would constitute a default or violation) of any term, condition or provision of (i) any loan or credit agreement, note, bond, mortgage, indenture, lease or other agreement, permit, franchise or license to which Highland
        Transcend or any of its subsidiaries is now a party or by which their respective properties or assets are bound or (ii) any statute or any judgment, order, rule or regulation of any court or governmental agency or body, domestic or foreign, having
        jurisdiction over Highland Transcend or any of its subsidiaries or their respective properties, except, in each such case, for defaults or violations that have not had and would not be reasonably expected to have, individually or in the aggregate,
        a Material Adverse Effect.

       

      
        4

        
          

        
          Confidential

        

      

      f.            Highland Transcend is in compliance with all applicable laws, except where such non-compliance would not, individually or in the aggregate,
        reasonably be expected to have a Material Adverse Effect. Except as disclosed in the current report on Form 8-K filed on May 28, 2021, Highland Transcend has not received any written communication from a governmental entity that alleges that
        Highland Transcend is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not be reasonably expected to have, individually or in the aggregate, a Material Adverse
        Effect.

       

      g.          A copy of each form, report, statement, schedule, prospectus, proxy, registration statement and other document, if any, filed by Highland
        Transcend with the SEC since its initial registration of its securities under the Exchange Act (the “SEC Documents”) is available to Investor via the SEC’s EDGAR system.  As of their respective filing dates, all SEC Documents complied in all
        material respects with the applicable requirements of the Securities Act of 1933, as amended, (the “Securities Act”) and the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the rules and regulations of the SEC
        promulgated thereunder, and none of the SEC Documents when filed or, if amended prior to the date of this Subscription Agreement, as of the date of such amendment with respect to those disclosures that are amended, contained any untrue statement of
        a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided,

        that with respect to the information about the Company and its subsidiaries and affiliates contained in the Schedule 14A and related proxy materials (or other SEC document) to be filed by Highland Transcend, the representation and warranty
        in this sentence is made to the best of Highland Transcend’s knowledge after due inquiry.  Except as disclosed in the current report on Form 8-K filed on May 28, 2021, Highland Transcend has timely filed each report, statement, schedule,
        prospectus, and registration statement that Highland Transcend was required to file with the SEC since its initial registration of its securities under the Exchange Act.  Except as has been disclosed in the SEC Documents, the financial statements
        of Highland Transcend included in the SEC Documents, when filed, complied in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing and fairly
        presented in all material respects the financial position of Highland Transcend as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
        year-end audit adjustments. There are no material outstanding or unresolved comments in comment letters from the staff of the Division of Corporation Finance of the SEC with respect to any of the SEC Documents.

       

      h.          Except for such matters as have not had and would not be reasonably expected to have, individually or in the aggregate, a Material Adverse
        Effect, there is no (i) action, suit, claim or other proceeding, in each case by or before any governmental authority pending, or, to the knowledge of Highland Transcend, threatened against Highland Transcend or the Company or (ii) judgment,
        decree, injunction, ruling or order of any governmental entity or arbitrator outstanding against Highland Transcend or the Company.

       

      i.            Other than the Placement Agents (as defined below), Highland Transcend has not dealt with any broker, finder, commission agent, placement
        agent or arranger in connection with the sale of the Shares, and Highland Transcend is not under any obligation to pay any broker’s fee or commission in connection with the sale of the Shares other than to the Placement Agents.  Neither Highland
        Transcend nor any of its affiliates nor any other person acting on its behalf (other than its officers acting in such capacity) has solicited offers for, or offered or sold, the Shares other than through the Placement Agents.  No broker, finder or
        other financial consultant has acted on behalf of Placement Agents in connection with this Subscription Agreement or the transactions contemplated hereby in such a way as to create any liability on Investor.

       

      j.            As of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor in
        accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid and non-assessable and will not have been issued in violation of or subject to any preemptive or similar rights created under Highland
        Transcend’s certificate of incorporation or bylaws (as in effect as of the Closing) or under the General Corporation Law of the State of Delaware.

       

      
        5

        
          

        
          Confidential

        

      

      k.          As of the date of this Subscription Agreement, the authorized capital stock of Highland Transcend consists of 1,000,000 preference shares (the
        “Preferred Shares”), 200,000,000 Class A ordinary shares the (“Class A Shares”), and 20,000,000 Class B ordinary shares (the “Class B Shares”), each par value $0.0001 per share. As of the date of this Subscription Agreement, (i) no Preferred Shares
        are issued and outstanding, (ii) 30,000,000 Class A Shares are issued and outstanding, (iii) 7,500,000 Class B Shares are issued and outstanding, and (iv) warrants to purchase an aggregate of 15,333,333 Class A Shares are issued and outstanding
        (the “Warrants”). All issued and outstanding Class A Shares, Class B Shares and Warrants have been duly authorized and validly issued, are fully paid and are non-assessable. Except as set forth above and pursuant to the Other Subscription
        Agreements, the Transaction Agreement and the other agreements and arrangements referred to therein, as of the date hereof, there are no outstanding options, warrants or other rights to subscribe for, purchase or acquire from Highland Transcend any
        Class A Shares, Class B Shares or other equity interests in Highland Transcend or securities convertible into or exchangeable or exercisable for such equity interests. As of the date hereof, Highland Transcend has no subsidiaries, other than the
        subsidiaries formed to consummate the Transaction, and does not own, directly or indirectly, interests or investments (whether equity or debt) in any person, whether incorporated or unincorporated. There are no stockholder agreements, voting trusts
        or other agreements or understandings to which Highland Transcend is a party or by which it is bound relating to the voting of any securities of Highland Transcend, other than as contemplated by the Transaction Agreement and the other agreements
        and arrangements referred to therein. There are no securities or instruments issued by or to which Highland Transcend is a party containing anti-dilution provisions that will be triggered by the issuance of (i) the Shares or (ii) the shares to be
        issued pursuant to any Other Subscription Agreement that have not been or will not be validly waived on or prior to the Closing Date.

       

      l.            Other than pursuant to the Other Subscription Agreements and the Transaction Agreement and the other agreements and arrangements referred to
        therein, Highland Transcend has not entered into any side letter or similar agreement or understandings (including written summaries of any oral understandings) with any investor in connection with such investor’s direct or indirect investment in
        Highland Transcend or with any other investor.  The Other Subscription Agreements reflect the same Per Share Price, and no Other Subscription Agreement includes terms and conditions (economic or otherwise) that are more advantageous to any such
        Other Investor than the Investor hereunder, other than terms particular to the regulatory requirements of such Other Investor or its affiliates or related funds that are mutual funds or are otherwise subject to regulations related to the timing of
        funding and the issuance of the Shares..  The Other Subscription Agreements have not been amended in any material respect following the date of this Subscription Agreement.

       

      m.          Assuming the accuracy of Investor’s representations and warranties set forth in Section 7 of this Subscription Agreement, no registration under
        the Securities Act is required for the offer and sale of the Shares by Highland Transcend to Investor.

       

      n.          Neither Highland Transcend nor any person acting on its behalf has offered or sold the Shares by any form of general solicitation or general
        advertising, including, but not limited to, the following:  (1) any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or broadcast over television or radio; (2) any website posting or
        widely distributed email; or (3) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

       

      o.          The issued and outstanding Class A Shares as of the date hereof are registered pursuant to Section 12(b) of the Exchange Act, and are listed
        for trading on the NYSE. As of the date hereof, there is no suit, action, proceeding or investigation pending or, to the knowledge of Highland Transcend, threatened against the Highland Transcend by the NYSE or the SEC, respectively, to prohibit or
        terminate the listing of the Class A Shares or, when issued, the Shares, or to deregister the Class A Shares or, when registered and issued in connection with the Domestication, the Shares, under the Exchange Act. Highland Transcend has taken no
        action that is designed to terminate the registration of the Class A Shares under the Exchange Act, other than in connection with the Domestication and subsequent registration under the Exchange Act of the Shares.

       

      6.           [Reserved]

       

      7.           Investor Representations and Warranties. The Investor represents and warrants to Highland Transcend that:

       

      a.           The Investor (i) is an “accredited investor” (within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act), in each case, satisfying the applicable requirements set forth on Schedule A, (ii) an “Institutional Account”
        as defined in FINRA Rule 4512(c), (iii) a sophisticated institutional investor, experienced in investing in private equity transactions and capable of evaluating investment risks independently, both in general and with regard to all transactions
        and investment strategies involving a security or securities, including its participation in the Transaction, (iv) is acquiring the Shares only for its own account and not for the account of others, or if the Investor is subscribing for the Shares
        as a fiduciary or agent for one or more investor accounts, the Investor has full investment discretion with respect to each such account, and the full power and
        authority to make the acknowledgements, representations and agreements herein on behalf of each owner of each such account, and (v) is not acquiring the Shares with a view to, or for offer or sale in connection with, any distribution thereof in
        violation of the Securities Act (and shall provide the requested information on Schedule A). The Investor is not an entity formed for the specific purpose of acquiring the Shares.

       

      
        6

        
          

        
          Confidential

        

      

      b.          The Investor understands that the Shares are being offered in a transaction not involving any public offering within the meaning of the Securities Act and that the Shares have not been registered under the Securities Act. The Investor understands that the Shares may not
        be resold, transferred, pledged or otherwise disposed of by the Investor absent an effective registration statement under the Securities Act
        except (i) to Highland Transcend or a subsidiary thereof, (ii) to non-U.S. persons pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant to another applicable
        exemption from the registration requirements of the Securities Act, and in each of cases (i) and (iii) in accordance with any applicable securities laws of the states and other jurisdictions of the United States, and that any certificates or book
        entry positions representing the Shares shall contain a restrictive legend to such effect; as a result the Investor may not be able to readily resell the Shares and may be required to bear the financial risk of an investment in the Shares for an
        indefinite period of time. The Investor acknowledges that the Shares will not immediately be eligible for resale pursuant to Rule 144 under the Securities Act. The Investor understands that it has been advised to consult legal counsel prior to
        making any offer, resale, pledge or transfer of any of the Shares.

       

      c.          The Investor understands and agrees that the Investor is purchasing the Shares from Highland Transcend. The Investor further acknowledges that
        there have been no representations, warranties, covenants and agreements made to the Investor by Highland Transcend or any of its officers or directors, expressly or by implication, other than, in the case of Highland Transcend, those
        representations, warranties, covenants and agreements included in the Subscription Agreement.

       

      d.          The Investor acknowledges and agrees that the Investor has had access to the offering materials made available to it in connection with the
        Transaction, and has received such information as the Investor deems necessary in order to make an investment decision with respect to the Shares, including, with respect to Highland Transcend, the Transaction and the business of Highland
        Transcend. Without limiting the generality of the foregoing, the Investor acknowledges that it has had an opportunity to review the SEC Documents. The Investor represents and agrees
        that the Investor and the Investor’s professional advisor(s), if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the Investor and such Investor’s professional advisor(s), if any, have
        deemed necessary to make an investment decision with respect to the Shares. The Investor has conducted its own independent due diligence with respect to the Transaction.  Based on such information as such Investor has deemed appropriate and without
        reliance upon the Placement Agents, such Investor has independently made its own analysis and decision to enter into the Transaction.  Except for the representations, warranties and agreements of Highland Transcend expressly set forth in the
        Subscription Agreement, the Investor is relying on its own sources of information, investment analysis and due diligence (including professional advice it may deem appropriate) with respect to the Transaction, the Shares and the business, condition
        (financial and otherwise), management, operations, properties and prospects of Highland Transcend, including but not limited to all business, legal, regulatory, accounting, credit and tax matters.

       

      e.           The Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and Highland Transcend or a
        representative of Highland Transcend or by means of contact from Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, or BofA Securities, Inc. or any of their affiliates (the “Placement Agents”), and the Shares were offered to the Investor solely by direct contact between the Investor and Highland Transcend or a representative of Highland Transcend or by contact between
        the Investor and the Placement Agents. The Investor did not become aware of this offering of the Shares, nor were the Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares were not offered to the Investor by
        any form of advertising or general solicitation and are not being offered to it in a manner involving a public offering under, or in a distribution in violation of, the Securities Act, or any state securities laws. Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation, Highland Transcend, the Placement Agents or their
          respective affiliates or any of their control persons, officers, directors, employees or representatives), other than the representations and warranties of Highland Transcend in making its investment or decision to invest in Highland Transcend
          and the Shares. The Investor further acknowledges that the Placement Agents have not made, do not make and shall not be deemed to make any express or implied representation or warranty with respect to Highland Transcend, this offering, or the
          Transaction.

       

      
        7

        
          

        
          Confidential

        

      

      f.           The Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares, including
        those set forth in Highland Transcend’s filings with the SEC. The Investor has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor has
        sought such accounting, legal and tax advice as the Investor has considered necessary to make an informed investment decision.

       

      g.          Alone, based on its own independent review or with such professional advice as it deems appropriate, the Investor has adequately analyzed and
        fully considered the risks of an investment in the Shares and determined that the investment in the Shares is consistent with its financial needs, objectives and condition and that the Investor is able at this time and in the foreseeable future to
        bear the economic risk of a total loss of the Investor’s investment in Highland Transcend. The Investor acknowledges specifically that a possibility of total loss exists.

       

      h.          The Investor has not relied on any statements or other information provided by or on behalf of the Placement Agents or any of their affiliates
        or any of their control persons, offices, directors, employees or representatives concerning Highland Transcend, the Transaction, the Transaction Agreement, the Subscription Agreement, or the transactions contemplated hereby or thereby, the Shares
        or the offer and sale of the Shares.

       

      i.           The Investor acknowledges that the Placement Agents: (i) have not provided the Investor with any information or advice with respect to the
        Shares, (ii) have not made or make any representation, express or implied as to Highland Transcend, the Company, the Company’s credit quality, the Shares or the Investor’s purchase of the Shares, and (ii) may have existing or future business
        relationships with Highland Transcend and the Company (including, but not limited to, lending, depository, risk management, advisory and banking relationships) and will pursue actions and take steps that it deems or they deem necessary or
        appropriate to protect its or their interests arising therefrom without regard to the consequences for a holder of Shares, and that certain of these actions may have material and adverse consequences for a holder of Shares.

       

      j.           The Investor acknowledges that it has not relied on the Placement Agents in connection with its determination as to the legality of its
        acquisition of the Shares or as to the other matters referred to herein and the Investor has not relied on any investigation that the Placement Agents, any of their affiliates or any person acting on their behalf have conducted with respect to the
        Shares, Highland Transcend or the Company. The Investor further acknowledges that it has not relied on any information contained in any research reports prepared by the Placement Agents or any of their affiliates.

       

      k.           The Investor understands and agrees that no federal or state agency has passed upon or endorsed the merits of the offering of the Shares or
        made any findings or determination as to the fairness of an investment in the Shares.

       

      l.           The Investor has been duly formed or incorporated and is validly existing in good standing under the laws of its jurisdiction of incorporation
        or formation, with power and authority to enter into, deliver and perform its obligations under this Subscription Agreement, and this Subscription Agreement has been duly authorized, validly executed and delivered by Investor.

       

      m.         The execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have been duly
        authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which
        the Investor is a party or by which the Investor is bound which would reasonably be expected to have a material adverse effect on the legal authority of the Investor to enter into and perform its obligations under this Subscription Agreement. The
        signature on this Subscription Agreement is genuine, and the signatory, if the Investor is an individual, has legal competence and capacity to execute the same or, if the Investor is not an individual the signatory has been duly authorized to
        execute the same, and this Subscription Agreement constitutes a legal, valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms except as may be limited or otherwise affected by (i) bankruptcy,
        insolvency, fraudulent conveyance, reorganization, moratorium or other laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law or equity.

       

      
        8

        
          

        
          Confidential

        

      

      n.           The execution, delivery and performance by Investor of this Subscription Agreement and the consummation of the transactions contemplated
        herein do not and will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or
        assets of Investor or any of its subsidiaries, if applicable, pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement, lease, license or other agreement or instrument to which Investor or, if applicable, any of its
        subsidiaries is a party or by which Investor or, if applicable, any of its subsidiaries is bound or to which any of the property or assets of Investor or, if applicable, any of its subsidiaries is subject, which would be reasonably likely to
        materially affect the legal authority of Investor to comply in all material respects with Investor’s obligations under this Subscription Agreement, (ii) the organizational documents of Investor, or (iii) any statute or any judgment, order, rule or
        regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over Investor or, if applicable, any of its subsidiaries or any of their respective properties that would be reasonably likely to materially affect the
        legal authority of Investor to comply in all material respects with Investor’s obligations under this Subscription Agreement.

       

      o.           The Investor is not (i) a person or entity named on the List of Specially Designated
        Nationals and Blocked Persons administered by the U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued by the President of the United States and
        administered by OFAC (“OFAC List”), or a person or entity prohibited by any OFAC sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (iii) a non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank. The Investor agrees to provide law
        enforcement agencies, if requested thereby, such records as required by applicable law, provided that the Investor is permitted to do so under applicable law. If the Investor is a financial institution subject to the Bank Secrecy Act (31 U.S.C.
        Section 5311 et seq.) (the “BSA”), as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the “BSA/PATRIOT

          Act”), the Investor maintains policies and procedures reasonably designed to comply with applicable obligations under the BSA/PATRIOT Act. To the extent required, the Investor maintains policies and procedures reasonably designed for the
        screening of its investors against the OFAC sanctions programs, including the OFAC List. To the extent required by applicable law, the Investor maintains policies and
        procedures reasonably designed to ensure that the funds held by the Investor and used to purchase the Shares were legally derived.

       

      p.           No disclosure or offering document has been provided to the Investor by the Placement Agents in connection with the offer and sale of the
        Shares.

       

      q.          The Investor acknowledges that the Placement Agents and each of their directors, officers, employees, representatives, other controlling
        persons, legal counsel, financial advisors, accountants or agents (collectively, the “Representatives”) have made no independent investigation with respect to Highland Transcend or the Shares or the accuracy, completeness or adequacy of any
        information supplied to the Investor by Highland Transcend. Investor acknowledges and agrees that neither the Placement Agents nor any Representative of the Placement Agents has provided Investor with any
        information or advice with respect to the Shares nor is such information or advice necessary or desired.  Investor acknowledges that J.P. Morgan Securities LLC and BofA Securities, Inc. are jointly engaged by Highland Transcend and the Company to
        act as joint placement agents in connection with (i) this private placement of Shares by Highland Transcend and (ii) a separate offering of convertible notes by the Company in connection with the transaction. Goldman Sachs, LLC has been engaged by
        Highland Transcend.  Investor acknowledges that Goldman Sachs & Co., LLC is acting solely as the Highland Transcend’s placement agent in connection with the sale of the Shares. The Investor acknowledges that the Placements Agents are not acting
        as underwriters or in any other capacity and are not and shall not be construed as fiduciaries or financial advisors for the Investor, Highland Transcend or any other person or entity.

       

      r.           In connection with the issue and purchase of the Shares, the Placement Agents have not acted as the Investor’s financial advisors or
        fiduciaries and the Investor has exercised independent judgment in evaluating its participation in the purchase of the Shares. The Placement Agent has not made or will make any representation or warranty, whether express or implied, of any kind or
        character and has not provided any advice or recommendation in connection with the Transaction, and the Placement Agents will not have any responsibility with respect to (i) any representations, warranties or agreements made by any person or entity
        under or in connection with the Transaction or any of the documents furnished pursuant thereto or in connection therewith, or the execution, legality, validity or enforceability (with respect to any person) or any thereof, or (ii) the business,
        affairs, financial condition, operations, properties or prospects of, or any other matter concerning Highland Transcend or the Transaction.

       

      
        9

        
          

        
          Confidential

        

      

      s.            Investor acknowledges that it is aware that J.P. Morgan Securities LLC is acting as financial advisor to the Company in connection with the
        Transaction.

       

      t.            [Reserved]

       

      u.           The Investor at the Closing will have sufficient funds to pay the Subscription Amount and consummate the
          purchase and sale of the Shares when required pursuant to this Subscription Agreement.

       

      v.           The Investor represents and warrants that its acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited
        transaction under Section 406 of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), or any applicable similar law.

       

      w.           If the Investor is an employee benefit plan that is subject to Title I of ERISA, a plan, an individual retirement account or other arrangement
        that is subject to section 4975 of the Code or an employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4) of
        ERISA) or other plan that is not subject to the foregoing but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the Code, or an entity whose
        underlying assets are considered to include “plan assets” of any such plan, account or arrangement (each, a “Plan”) subject to the fiduciary or prohibited transaction provisions of ERISA or section 4975 of the Code, Investor represents and
        warrants that neither Highland Transcend, nor any of its respective affiliates (the “Transaction Parties”) has acted as the Plan’s fiduciary, or has been relied on for advice, with respect to its decision to acquire and hold the Shares, and
        none of the Transaction Parties shall at any time be relied upon as the Plan’s fiduciary with respect to any decision to acquire, continue to hold or transfer the Shares.

       

      x.           Except (i) as expressly disclosed in a Schedule 13D or Schedule 13G (or amendments thereto) filed by such Investor with the SEC with respect
        to the beneficial ownership of Highland Transcend’s equity securities prior to the date hereof and (ii) with respect to any affiliates of the Investor, the Investor is not currently (and at all times through Closing will refrain from being or
        becoming) a member of a “group” (within the meaning of Section (d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision), including any group acting for the purpose of acquiring, holding or disposing of equity securities of
        Highland Transcend (within the meaning of Rule 13d-5(b)(1) under the Exchange Act).

       

      
        10

        
          

        
          Confidential

        

      

      8.           Registration Rights.          .

       

      a.           In the event that the Shares are not registered for resale by the Investor in connection with the consummation of the Transaction, Highland
        Transcend agrees that, as soon as reasonably practicable (but in any case no later than thirty (30) calendar days after the consummation of the Transaction), it will file with the SEC (at its sole cost and expense) a registration statement
        registering such resale (the “Registration Statement”), and it shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after the filing thereof, but no later than the earlier
        of (i) the 60th calendar day (or 120th calendar day if the SEC notifies Highland Transcend that it will “review” the Registration Statement) following the Closing Date and (ii) the 10th business day after the date Highland Transcend is notified
        (orally or in writing, whichever is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further review. Highland Transcend agrees to cause such Registration Statement, or another shelf registration
        statement that includes the Shares to be sold pursuant to this Subscription Agreement, to remain effective until the earliest of (i) the third anniversary of the Closing, (ii) the date on which the Investor ceases to hold any Shares issued pursuant
        to this Subscription Agreement, or (iii) on the first date on which the Investor can sell all of its Shares issued pursuant to this Subscription Agreement (or shares received in exchange therefor) under Rule 144 of the Securities Act within 90 days
        without limitation as to the amount of such securities that may be sold and without the requirement for Highland Transcend to be in compliance with the current public information required under Rule 144(c)(i) (or Rule 144(i)(2), if applicable). The
        period of time during which Highland Transcend is required hereunder to keep a Registration Statement effective is referred to herein as the “Registration Period.”  Notwithstanding the foregoing, if the SEC prevents Highland Transcend from
        including any or all of the shares proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 of the Securities Act for the resale of the Shares by the applicable stockholders or otherwise, such
        Registration Statement shall register for resale such number of Shares which is equal to the maximum number of Shares as is permitted by the SEC. In such event, the number of Shares to be registered for each selling stockholder named in the
        Registration Statement shall be reduced pro rata among all such selling stockholders, and as promptly as practicable after being permitted to register additional shares under Rule 415 of the Securities Act, Highland Transcend shall amend the
        Registration Statement or file a new registration statement to register such shares that were not registered in the Registration Statement and cause such amendment or new registration statement to become effective as promptly as practicable. The
        Investor agrees to disclose its ownership to Highland Transcend upon reasonable request to assist it in making the determination described above. Highland Transcend may amend the Registration Statement so as to convert the Registration Statement to
        a Registration Statement on Form S-3 at such time after Highland Transcend becomes eligible to use such Form S-3. Highland Transcend’s obligations to include the Shares issued pursuant to this Subscription Agreement (or shares issued in exchange
        therefor) for resale in the Registration Statement are contingent upon the Investor furnishing in writing to Highland Transcend such information regarding the Investor, the securities of Highland Transcend held by the Investor and the intended
        method of disposition of such Shares, which shall be limited to non-underwritten public offerings, as shall be reasonably requested by Highland Transcend to effect the registration of such Shares, and shall execute such documents in connection with
        such registration as Highland Transcend may reasonably request that are customary of a selling stockholder in similar situations provided that the Investor shall not in connection with the foregoing be required to execute any lock-up or similar
        agreement or otherwise be subject to any contractual restriction on its ability to transfer the Shares. With respect to the information to be provided by the undersigned pursuant to this Section 8(a), Highland Transcend shall request such
        information at least five (5) business days prior to the anticipated initial filing date of the Registration Statement. In no event shall the Investor be identified as a statutory underwriter in the Registration Statement unless requested by the
        SEC; provided that if the SEC requests that the Investor be identified as a statutory underwriter in the Registration Statement, the Investor will have an opportunity to withdraw from the Registration Statement.  If the Commission determines that
        any resale of the Subscribed Shares is deemed a primary offering, the Company will use its commercially reasonable efforts to dispute the Commission’s determination.  Notwithstanding the foregoing, if the Commission prevents the Company from
        including any or all of the shares proposed to be registered under the Registration Statement due to limitations on the use of Rule 415 under the Securities Act for the resale of the Subscribed Shares by the applicable stockholders or otherwise,
        such Registration Statement shall register for resale such number of Subscribed Shares which is equal to the maximum number of Subscribed Shares as is permitted to be registered by the Commission. In such event, the number of Subscribed Shares to
        be registered for each selling stockholder named in the Registration Statement shall be reduced pro rata among all such selling stockholders.  The undersigned agrees to disclose its beneficial ownership, as determined in accordance with Rule 13d-3
        under the Exchange Act, of Subscribed Shares to the Company upon request to assist the Company in making the determination described above.  For purposes of this Section 8, “Shares” shall be deemed to include, as of any date of determination, the
        Shares acquired pursuant to this Subscription Agreement and any equity security issued or issuable with respect to such Shares by way of share split, dividend, distribution, recapitalization, merger, exchange, replacement or similar event, and
        “Investor” shall mean the Investor or any affiliate of Investor or other person to whom the rights under this Section 8 shall have been assigned.

       

      b.           In the case of the registration effected by Highland Transcend pursuant to this Subscription Agreement, Highland Transcend shall, upon
        reasonable request, inform the Investor as to the status of such registration. At its expense and during the Registration Period, Highland Transcend shall:

       

      (i)          except for such times as Highland Transcend is permitted hereunder to suspend the use of the prospectus forming part of a
        Registration Statement, use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state securities laws which Highland Transcend determines to obtain, continuously effective with respect
        to the Investor, and to keep the applicable Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions;

       

      
        11

        
          

        
          Confidential

        

      

      (ii)         advise the Investor within five (5) business days: (A) when a Registration Statement or any post-effective amendment
        thereto has become effective; (B) of the issuance by the SEC of any stop order suspending the effectiveness of any Registration Statement or the initiation of any proceedings for such purpose; (C) of the receipt by Highland Transcend of any
        notification with respect to the suspension of the qualification of the Shares included in the Registration Statement for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and (D) subject to the
        provisions in this Subscription Agreement, of the occurrence of any event that requires the making of any changes in any Registration Statement or prospectus so that, as of such date, the statements therein are not misleading and do not omit to
        state a material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, in the light of the circumstances under which they were made) not misleading;

       

      Notwithstanding anything to the contrary set forth in this Section 8(b)(ii), Highland Transcend shall not, when so advising the Investor of such events, provide the Investor with any material,
        nonpublic information regarding Highland Transcend other than to the extent that providing notice to the Investor of the occurrence of the events listed in (A) through (D) above constitutes material, nonpublic information regarding Highland
        Transcend;

       

      (iii)         use its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of any
        Registration Statement as soon as reasonably practicable;

       

      (iv)       upon the occurrence of any event contemplated in Section 8(b)(ii)(D), except for such times as Highland Transcend is
        permitted hereunder to suspend, and has suspended, the use of a prospectus forming part of a Registration Statement, Highland Transcend shall use its commercially reasonable efforts to as soon as reasonably practicable prepare a post-effective
        amendment to such Registration Statement or a supplement to the related prospectus, or file any other required document so that, as thereafter delivered to purchasers of the Shares included therein, such prospectus will not include any untrue
        statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; and

       

      (v)          use its commercially reasonable efforts to cause all Shares to be listed on each securities exchange or market, if any, on
        which the Shares are then listed;

       

      c.          The Investor agrees that Highland Transcend may suspend the use of any such Registration Statement (a “Suspension Event”) if it
        determines that in order for such Registration Statement not to contain a material misstatement or omission, an amendment thereto would be needed to include information that would at that time not otherwise be required in a current, quarterly, or
        annual report under the Exchange Act, provided that Highland Transcend shall not so suspend the use of the Registration Statement on more than three occasions, or for a period of more than sixty (60) consecutive calendar days or more than a total
        of ninety (90) calendar days, in each case in any twelve (12)-month period, and shall use commercially reasonable efforts to make such Registration Statement available for the sale by the Investor of such securities as soon as practicable
        thereafter. Upon receipt of any written notice from Highland Transcend of the happening of any Suspension Event during the period that the Registration Statement is effective or if as a result of a Suspension Event the Registration Statement or
        related prospectus contains any untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made (in the case
        of the prospectus) not misleading, the Investor agrees that (i) it will promptly discontinue offers and sales of the Shares under the Registration Statement until such Investor receives copies of a supplemental or amended prospectus (which Highland
        Transcend agrees to promptly prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment has become effective or unless otherwise notified by Highland Transcend that it may
        resume such offers and sales, and (ii) it will maintain the confidentiality of any information included in such written notice delivered by Highland Transcend unless otherwise required by law or subpoena.

       

      
        12

        
          

        
          Confidential

        

      

      d.           Highland Transcend shall indemnify and hold harmless Investor (to the extent a seller under the Registration Statement), the officers,
        directors, agents, investment advisers and employees of Investor, each person who controls Investor (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, agents and employees of each
        such controlling person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”)

        that arise out of or are based upon any untrue or alleged untrue statement of a material fact contained in the Registration Statement, any prospectus included in the Registration Statement or any form of prospectus or in any amendment or supplement
        thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or form of
        prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, except to the extent that such untrue statements, alleged untrue statements, omissions or alleged omissions are based upon information
        regarding Investor furnished in writing to Highland Transcend by Investor expressly for use therein or that Investor has omitted a material fact from such information.

       

      e.           Investor shall, severally and not jointly with any Other Investor or other selling stockholder named in the Registration Statement, indemnify
        and hold harmless Highland Transcend, its directors, officers, agents and employees, each person who controls Highland Transcend (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors,
        officers, agents or employees of such controlling persons, to the fullest extent permitted by applicable law, from and against all Losses arising out of or based upon any untrue or alleged untrue statement of a material fact contained in any
        Registration Statement, any prospectus included in the Registration Statement, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission
        of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus, or any form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
        to the extent, but only to the extent, that such untrue statements, alleged untrue statements, omissions or alleged omissions are based upon information regarding Investor furnished in writing to Highland Transcend by Investor expressly for use
        therein. In no event shall the liability of Investor be greater in amount than the dollar amount of the net proceeds received by Investor upon the sale of the Shares giving rise to such indemnification obligation.

       

      f.           Any person or entity entitled to indemnification herein shall (i) give prompt written notice to the indemnifying party of any claim with
        respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person’s or entity’s right to indemnification hereunder to the extent such failure has not prejudiced the indemnifying party) and (ii)
        unless in such indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim with counsel
        reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not be
        unreasonably withheld, conditioned or delayed). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified
        by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim.
        No indemnifying party shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the
        indemnifying party pursuant to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such indemnified party or which does not include as an unconditional term thereof the giving
        by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation.

       

      g.           The indemnification provided for under this Subscription Agreement shall remain in full force and effect regardless of any investigation made
        by or on behalf of the indemnified party or any officer, director or controlling person or entity of such indemnified party and shall survive the transfer of securities.

       

      
        13

        
          

        
          Confidential

        

      

      h.          If the indemnification provided under this Section 8 from the indemnifying party is unavailable or insufficient to hold harmless an indemnified
        party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a
        result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations;
        provided, however, the liability of the Investor under this Section 8(h), when combined with any amounts owed under Section 8(e), shall be limited to the dollar amount of the net proceeds received by the Investor upon the sale of Shares giving rise
        to such contribution obligation. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue statement of a
        material fact or omission or alleged omission to state a material fact, was made by (or not made by, in the case of an omission), or relates to information supplied by (or not supplied by, in the case of an omission), such indemnifying party or
        indemnified party, and the indemnifying party’s and indemnified party’s relative intent, knowledge, access to information and opportunity to correct or prevent such action. The amount paid or payable by a party as a result of the losses or other
        liabilities referred to above shall be deemed to include, subject to the limitations set forth in this Section 8, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation or proceeding. No
        person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution pursuant to this Section 8(f) from any person or entity who was not guilty of such fraudulent
        misrepresentation.

       

      9.           Additional Agreements.

      

      

      a.           The Investor hereby agrees that, from the date of this Subscription Agreement, none of Investor, its controlled affiliates, or any person or
        entity acting on behalf of Investor or any of its controlled affiliates or pursuant to any understanding with Investor or any of its controlled affiliates will engage in any Short Sales with respect to securities of Highland Transcend prior to the
        Closing. For purposes of this Section 9, “Short Sales” shall include, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, and all types of direct and indirect stock pledges
        (other than pledges in the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions
        through non-U.S. broker dealers or foreign regulated brokers. Notwithstanding the foregoing, (i) nothing herein shall prohibit other entities under common management with the Investor that have no knowledge of this Subscription Agreement or of the
        Investor’s participation in the Transaction (including the Investor’s controlled affiliates and/or affiliates) from entering into any Short Sales, (ii) in the case of an Investor that is a multi-managed investment vehicle whereby separate portfolio
        managers manage separate portions of such Investor’s assets and the portfolio managers have no knowledge of the investment decisions made by the portfolio managers managing other portions of such Investor’s assets, this Section 9 shall only apply
        with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Subscription Amount covered by this Subscription Agreement and (iii) nothing herein shall prohibit the Investor or any of its
        affiliates from entering into Short Sales in the ordinary course of business, consistent with managing its portfolio exposure or otherwise consistent with past practice.

       

      b.           With a view to making available to the Investor the benefits of Rule 144, for so long as the Investor holds the Shares acquired pursuant to
        this Subscription Agreement, Highland Transcend agrees to use its commercially reasonable efforts to file all reports and other materials to be filed by the Exchange Act so long as Highland Transcend remains subject to such requirements and the
        filing of such reports and other materials is required for the applicable provisions of Rule 144 to enable Highland Transcend to sell the Shares under Rule 144. So long as the Investor holds the Shares acquired pursuant to this Subscription
        Agreement, Highland Transcend agrees to furnish to the Investor promptly upon request, (x) a written statement by Highland Transcend, if true, that it has complied with the reporting requirements of Rule 144, the Securities Act and the Exchange
        Act, (y) a copy of the most recent annual or quarterly report of Highland Transcend and such other reports and documents so filed by Highland Transcend (it being understood that the availability of such report on the SEC’s EDGAR system shall
        satisfy this requirement) and (z) such other information as may be reasonably requested in writing to permit the Investor to sell such securities pursuant to Rule 144 without registration.

       

      c.          Subject to receipt from the Investor by Highland Transcend and the Transfer Agent of customary representations and other documentation
        reasonably acceptable to Highland Transcend in connection therewith, the Investor may request that Highland Transcend remove any legend from the book entry position evidencing the Shares purchased hereunder and Highland Transcend will, if required
        by the Transfer Agent, use its commercially reasonable efforts to cause an opinion of Highland Transcend’s counsel be provided, in a form reasonably acceptable to the Transfer Agent to the effect that the removal of such restrictive legends in such
        circumstances may be effected under the Securities Act, if such Shares (1) have been sold or transferred pursuant to an effective registration statement, (2) have been sold pursuant to Rule 144, or (3) are eligible for resale under Rule 144(b)(1)
        or any successor provision without the requirement for Highland Transcend to be in compliance with the current public information requirement under Rule 144 and without volume or manner-of-sale restrictions applicable to the sale or transfer of
        such Shares, or another exemption from registration. If restrictive legends are no longer required for such Shares pursuant to the foregoing, Highland Transcend shall, in accordance with the provisions of this section and within four (4) trading
        days of any request therefor from the Investor accompanied by such customary and reasonably acceptable representations and other documentation referred to above establishing that restrictive legends are no longer required, deliver to the Transfer
        Agent irrevocable instructions to make a new, unlegended entry for such book entry Shares. Highland Transcend shall be responsible for the fees of its transfer agent, its legal counsel and all DTC fees associated with such issuance.

       

      
        14

        
          

        
          Confidential

        

      

      d.           Highland Transcend shall, by 9:00 a.m., New York City time, on the first (1st) business day immediately following the date of this
        Subscription Agreement, issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”) disclosing all material terms of the transactions contemplated hereby, by the Other Subscription
        Agreements and by, the Transaction Agreement and any other material, nonpublic information regarding the Transaction, Highland Transcend or the Company that Highland Transcend provided to the Investor prior to the date hereof.  Upon the issuance of
        the Disclosure Document, to Highland Transcend’s knowledge, the Investor shall not be in possession of any material, nonpublic information received from Highland Transcend or any of its officers, directors, or employees or agents, and the Investor
        shall no longer be subject to any confidentiality or similar obligations under any current agreement, whether written or oral with Highland Transcend, the Placement Agents, or any of their respective affiliates in connection with the Transaction. 
        Notwithstanding anything in this Subscription Agreement to the contrary, Highland Transcend (i) shall not publicly disclose the name of the Investor or any of its affiliates or advisers, or include the name of the Investor or any of its affiliates
        or advisers in any press release, investor presentations or marketing materials, without the prior written consent of the Investor and (ii) shall not publicly disclose the name of the Investor or any of its affiliates or advisers, or include the
        name of the Investor or any of its affiliates or advisers in any filing with the SEC or any regulatory agency or trading market, without the prior written consent of the Investor, except as required by the federal securities law, regulatory agency
        or under the regulations of NYSE, in which case Highland Transcend shall provide the Investor with prior written notice of such disclosure permitted hereunder.

       

      10.         Termination. This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the
        parties hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earlier to occur of (a) such date and time as the Transaction Agreement is terminated in accordance with its terms without being
        consummated, (b) upon the mutual written agreement of each of the parties hereto to terminate this Subscription Agreement, (c) if any of the conditions to Closing set forth in Section 2 of this Subscription Agreement
        are not satisfied or waived, or are not capable of being satisfied, on or prior to the Closing and, as a result thereof, the transactions contemplated by this
        Subscription Agreement will not be and are not consummated at the Closing or (d) by 5:00 PM on March 31, 2022 if the Closing has not occurred by such date (or, if extended pursuant to Section 12.01 of the Transaction Agreement, by such later date
        not to exceed 60 additional calendar days after March 31, 2022); provided that nothing herein will relieve any party from liability for any willful breach hereof prior to the time of termination, and each party will be entitled to any remedies at
        law or in equity to recover losses, liabilities or damages arising from any such breach. Highland Transcend shall notify the Investor of the termination of the Transaction Agreement promptly after the termination of the Transaction Agreement.

       

      11.        Trust Account Waiver. The Investor acknowledges that Highland Transcend is a blank check company
        with the powers and privileges to effect a merger, asset acquisition, reorganization or similar business combination involving Highland Transcend and one or more businesses or assets. The Investor further acknowledges that, as described in Highland
        Transcend’s prospectus relating to its initial public offering dated December 2, 2020 (the “Prospectus”) available at www.sec.gov, substantially all of
        Highland Transcend’s assets consist of the cash proceeds of Highland Transcend’s initial public offering and private placement of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust
            Account”) for the benefit of Highland Transcend, its public shareholders and the underwriter of Highland Transcend’s initial public offering. Except with respect to interest earned on the funds held in the Trust Account that may be
        released to Highland Transcend to pay its tax obligations, if any, the cash in the Trust Account may be disbursed only for the purposes set forth in the Prospectus. For and in consideration of Highland Transcend entering into this Subscription
        Agreement, the receipt and sufficiency of which are hereby acknowledged, the Investor hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may have in the future, in or to any monies held in the Trust
        Account, and agrees not to seek recourse against the Trust Account as a result of, or arising out of, this Subscription Agreement provided, however, that nothing in this Section 11 shall (a) serve to limit or prohibit the Investor’s right to pursue
        a claim against Highland Transcend for legal relief against assets held outside the Trust Account (so long as such claim would not affect Highland Transcend’s ability to fulfill its obligation to effectuate any redemption right with respect to any
        securities of Highland Transcend), for specific performance or other equitable relief, (b) serve to limit or prohibit any claims that the Investor may have in the future against Highland Transcend’s assets or funds that are not held in the Trust
        Account (including any funds that have been released from the Trust Account and any assets that have been purchased or acquired with any such funds) so long as such claim would not affect Highland Transcend’s ability to fulfill its obligation to
        effectuate any redemption right with respect to any securities of Highland Transcend or (c) be deemed to limit the Investor’s right to distributions from the Trust Account in accordance with Highland Transcend’s amended and restated memorandum and
        articles of association as in effect prior to the Domestication in respect of Class A Shares acquired by any means other than pursuant to this Subscription Agreement.

       

      
        15

        
          

        
          Confidential

        

      

      12.         Miscellaneous.

       

      a.           Neither this Subscription Agreement nor any rights that may accrue to the Investor hereunder (other than the Shares acquired hereunder, and
        the rights set forth in Section 8) may be transferred or assigned. Neither this Subscription Agreement nor any rights that may accrue to Highland Transcend hereunder may be transferred or assigned (provided, that, for the avoidance of doubt,
        Highland Transcend may transfer the Subscription Agreement and its rights hereunder solely in connection with the consummation of the Transaction and exclusively to another entity under the control of, or under common control with, Highland
        Transcend).  Notwithstanding the foregoing, the Investor may assign its rights and obligations under this Subscription Agreement to one or more of its affiliates or to other investment funds or accounts managed or advised by the investment manager
        who acts on behalf of the Investor, or, with Highland Transcend’s prior written consent, to another person, provided that (i) such assignee(s) agrees in writing to be bound by the terms hereof, and upon such assignment by the Investor, the
        assignee(s) shall have the rights and obligations of an Investor hereunder and be deemed to make the representations and warranties of the Investor provided for herein to the extent of such assignment and (ii) no such assignment shall relieve the
        Investor of its obligations hereunder if any such assignee fails to perform such obligations unless expressly agreed to in writing by Highland Transcend.

       

      b.          Highland Transcend may request from the Investor such additional information as they may deem necessary to register the resale of the Shares
        and evaluate the eligibility of the Investor to acquire the Shares, and the Investor shall promptly provide such information as may reasonably be requested, provided, that Highland Transcend agrees to keep any such information confidential.  The
        Investor acknowledges that subject to the conditions set forth in Section 9(d), Highland Transcend may file a copy of this Subscription Agreement with the SEC as an exhibit to a periodic report or other required filing with the SEC of Highland
        Transcend.

       

      c.          The Investor acknowledges that (i) Highland Transcend will rely on the acknowledgments, understandings, agreements,
        representations and warranties of the Investor contained in this Subscription Agreement and (ii) the Placement Agents will rely on the acknowledgments, understandings, agreements, representations and warranties of the Investor contained in Section
        7 and Section 13 this Subscription Agreement. Highland Transcend acknowledges that the Investor, the Placement Agents and others will rely on the acknowledgments, understandings, agreements, representations and warranties contained in this
        Subscription Agreement. Prior to the Closing, the Investor agrees to promptly notify Highland Transcend and the Placement Agents if any of the acknowledgments, understandings, agreements, representations and warranties set forth in Section 7 above
        are no longer accurate in any material respect (other than those acknowledgments, understandings, agreements, representations and warranties qualified by materiality, in which case the Investor shall notify Highland Transcend and the Placement
        Agents if they are no longer accurate in all respects). The Investor further acknowledges and agrees that the Placement Agents are third-party beneficiaries of the representations and warranties of the Investor contained in Section 7 and Section 13
        of this Subscription Agreement.

       

      d.           Highland Transcend, the Investor and the Placement Agents each is irrevocably authorized to produce this Subscription Agreement or a copy
        hereof to any interested party in any administrative or legal proceeding or official inquiry with respect to the matters covered hereby.

       

      e.           All of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

       

      
        16

        
          

        
          Confidential

        

      

      f.           This Subscription Agreement may not be modified, waived or terminated (other than pursuant to the terms of Section 10 above) except by an
        instrument in writing, signed by each of the parties hereto. No failure or delay of either party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power, or
        any abandonment or discontinuance of steps to enforce such right or power, or any course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies of the parties hereunder are
        cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder. Notwithstanding anything to the contrary herein, Section 7, Section 12(c), Section 12(d), this Section 12(f) and Section 13 may not be modified,
        waived or terminated in a manner that is material and adverse to the Placement Agents without the written consent of the Placement Agents.

       

      g.          This Subscription Agreement (including the schedule hereto) constitutes the entire agreement, and supersedes all other prior agreements,
        understandings, representations and warranties, both written and oral, among the parties, with respect to the subject matter hereof. Except as set forth in Section 8, Section 12(c), Section 12(d), Section 12(f) and Section 13 with respect to the
        persons referenced therein, this Subscription Agreement shall not confer any rights or remedies upon any person other than the parties hereto, and their respective successor and assigns.

       

      h.        Except as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their
        heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties, covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such
        heirs, executors, administrators, successors, legal representatives and permitted assigns.

       

      i.           If any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or
        unenforceable, the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected or impaired thereby and shall continue in full force and effect.

       

      j.          This Subscription Agreement may be executed and delivered in one or more counterparts (including by facsimile or electronic mail or in .pdf)
        and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document. All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.

       

      k.          The parties hereto agree that irreparable damage may occur in the event that any of the provisions of this Subscription Agreement were not
        performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be entitled to seek an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a
        bond or undertaking and without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to any other remedy to which such party is entitled at law, in equity, in contract, in tort or
        otherwise.

       

      l.           Any notice or communication required or permitted hereunder shall be in writing and either delivered personally, emailed or sent by overnight
        mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, and shall be deemed to be given and received (i) when so delivered personally, (ii) when sent, with no mail undeliverable or other rejection notice,
        if sent by email, or (iii) three business days after the date of mailing to the address below or to such other address or addresses as such person may hereafter designate by notice given hereunder:

       

      (i)          if to Investor, to such address(es) or email address(es) set forth herein;

       

      (ii)         if to Highland Transcend, to:

       

      Highland Transcend Partners I Corp.

      777 Arthur Godfrey Road, #202

      Miami Beach, FL 33140

      Attention:           Ian Friedman

      E-mail:                ian@highlandtranscend.com

       

      with a required copy to (which copy shall not constitute notice):

       

      Davis Polk & Wardwell LLP

      450 Lexington Ave

      New York, NY 10017

      Attention:              Derek Dostal

       Michael Davis

       Lee Hochbaum

      Email:      derek.dostal@davispolk.com

       michael.davis@davispolk.com

       lee.hochbaum@davispolk.com

       

      
        17

        
          

        
          Confidential

        

      

      m.          Each party shall pay all of its own expenses in connection with this Subscription Agreement and the transactions contemplated herein.

       

      n.          THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK
        AND THE SUPREME COURT OF THE STATE OF NEW YORK SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE TRANSACTIONS
        CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT
        BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL
        CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED BY SUCH A NEW YORK STATE OR FEDERAL COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT
        MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER PROVIDED IN SECTION 12(l) OF THIS SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW
        SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.

       

      EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE
        EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS
        CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
        LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO
        THIS SUBSCRIPTION AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 12(n).

       

      o.          If the Investor is a Massachusetts Business Trust, a copy of the Declaration of Trust of the Investor or any affiliate thereof is on file with
        the Secretary of State of the Commonwealth of Massachusetts and notice is hereby given that the Subscription Agreement is executed on behalf of the trustees of the Investor or any affiliate thereof as trustees and not individually and that the
        obligations of the Subscription Agreement are not binding on any of the trustees, officers or stockholders of the Investor or any affiliate thereof individually but are binding only upon the Investor or any affiliate thereof and its assets and
        property.

       

      
        18

        
          

        
          Confidential

        

      

      13.        Non-Reliance and Exculpation. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation or warranty made by any person, firm
        or corporation (including, without limitation, the Placement Agents, any of their affiliates or any of its or their Representatives), other than the statements, representations and warranties of Highland Transcend expressly contained in Section 5 of this Subscription Agreement in making its investment or decision to invest in Highland Transcend. The Investor agrees that none of (i) any Other Investor (including its controlling persons, officers, directors, partners, agents, or employees) or (ii) the Placement Agents, their affiliates or any of its or their control persons, officers, directors or
        employees shall be liable to the Investor, pursuant to this Subscription Agreement related to the private placement of the Shares for any action heretofore or hereafter taken or omitted to be taken by any of them in connection with the purchase of
        the Shares or have any liability or obligation (including without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred by you, Highland
        Transcend or any other person or entity), whether in contract, tort or otherwise, to any Investor, or to any person claiming through such Investor, in respect of the Transaction.

       

      14.         Separation Obligations. The obligations of the Investor under this Subscription Agreement are several and not joint with the obligations of any Other Investor, and the Investor
        shall not be responsible in any way for the performance of the obligations of any Other Investor.  The decision of the Investor to purchase the Shares pursuant to this Subscription Agreement has been made by the Investor independently of any Other
        Investor and independently of any information, materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial or otherwise) or prospects of Highland Transcend
        or any of its subsidiaries which may have been made or given by any Other Investor or by any agent or employee of any Other Investor, and neither the Investor nor any of its agents or employees shall have any liability to any Other Investor (or any
        other person) relating to or arising from any such information, materials, statements or opinions.  Nothing contained herein or in any Other Subscription Agreement, and no action taken by the Investor pursuant hereto or thereto, shall be deemed to
        constitute the Investor and Other Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investor and Other Investors are in any way acting in concert or as a group with respect to
        such obligations or the transactions contemplated by this Subscription Agreement and the Other Subscription Agreements.  The Investor acknowledges that no Other Investor has acted as agent for the Investor in connection with making its investment
        hereunder and no Other Investor will be acting as agent of the Investor in connection with monitoring its investment in the Shares or enforcing its rights under this Subscription Agreement.  The Investor shall be entitled to independently protect
        and enforce its rights, including without limitation the rights arising out of this Subscription Agreement, and it shall not be necessary for any Other Investor to be joined as an additional party in any proceeding for such purpose.

       

      [SIGNATURE PAGES FOLLOW]

      

      

      
        19

        
          

      

      IN WITNESS WHEREOF, the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative as of the date set
        forth below.

       

      	
              Name of Investor:

            	
              State/Country of Formation or Domicile:

            

      

      

      	
              By:

            	

            	

            

      	
              Name: 

              

            	

            	

            

      	
              Title: 

              

            	

            	

            

      

      

      	
              Name in which Shares are to be registered (if different):

            	
              Date: ________, 2021

            
	

            	

            
	
              Investor’s EIN (if applicable):

            	

            
	

            	

            
	
              Business Address-Street:

            	
              Mailing Address-Street (if different):

            
	

            	

            
	
              City, State, Zip:

            	
              City, State, Zip:

            

      

      

      	
              Attn:

            	

            	 	
              Attn: 

              

            	

            	 

      

      

      	
              Telephone No.:

            	 
	
              Facsimile No.:

            	 
	
              Email:

            	 
	
              Number of Shares subscribed for:

            	 
	 	 
	
              Aggregate Subscription Amount: $

            	
              Price Per Share: $10.00

            

       

      

      You must pay the Subscription Amount by wire transfer of United States dollars in immediately available funds to the account specified by Highland Transcend in the Closing Notice.

       

      
        20

        
          

      

      IN WITNESS WHEREOF, Highland Transcend Partners I Corp. has accepted this Subscription Agreement as of the date set forth below.

       

      	 	
              HIGHLAND TRANSCEND PARTNERS I CORP.

            

      

      

      	 	
              By:

            	

            	 

      	 	
              Name:

            
	 	
              Title:

            

      

      

      	
              Date:

            	
              , 2021

            

      

      

      
        21

        
          

      

      SCHEDULE A

      

      

      
        ELIGIBILITY REPRESENTATIONS OF THE INVESTOR

      

      
        

        

      

      	 	
              INSTITUTIONAL ACCREDITED INVESTOR STATUS

            
	 	
              (Please check the applicable subparagraphs):

            

       

      ☐  We are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which all of the equity
        holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have marked and initialed the appropriate box on the following page
        indicating the provision under which we qualify as an “accredited investor.”

       

      ☐  We are not a natural person.

      
        

        

      

      
        Under Rule 501(a), in relevant part, states that an “accredited investor” shall mean any person who comes within any
          of the below listed categories, or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that person. The Investor has indicated, by marking and initialing the appropriate
          box below, the provision(s) below which apply to the Investor and under which the Investor accordingly qualifies as an “accredited investor.”

      

      
        

        

        ☐  Any bank, registered broker or dealer, SEC- or state-registered investment adviser, exempt reporting adviser, insurance company, registered investment company, business development company, small business investment company, or rural business investment company;

         

        ☐  Any plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if
          such plan has total assets in excess of $5,000,000;

         

        ☐  Any employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

         

        ☐  Any organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, partnership or limited liability company not formed for the specific
          purpose of acquiring the securities offered, with total assets in excess of $5,000,000; or

         

        ☐  Any trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated person;

      

      
        

        

        This page should be completed by the Investor

      

      
        and constitutes a part of the Subscription Agreement.

      

      

      

      

      

      22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00333-of-00352.parquet"}]]